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Abstract
Chronic lung diseases affect millions of people in the United States and are a
leading cause of both morbidity and mortality. Studying how environmental factors affect
lung cell biology and function is being increasingly recognized as a critical step in
understanding lung disease pathogenesis and the development of new therapeutic
approaches that combat lung diseases. These factors include lung extracellular matrix
(ECM) composition and the mechanobiological factors of stiffness and cyclic mechanical
strain, which during breathing, act on cells during the normal expansion and contraction
of the lung. However, current methodologies for studying these factors have significant
limitations and new approaches are necessary, particularly for investigating how these
factors are altered in diseased lungs.
As such, the goal of this thesis was to develop and optimize new in vitro
methodologies that can be used to assess the effects of these three factors (ECM composition,
stiffness, and cyclic mechanical strain (stretch)) on lung cells under both normal and diseased
conditions, where idiopathic pulmonary fibrosis served as the disease model. I present work
from two independent sets of studies that were designed to investigate the effects of these
factors individually and in combinatorial fashion. The first study focused on how stiffness
and ECM composition, alone and in combination, can cause changes in a representative
relevant human lung cell type, human lung fibroblasts (HLF). A novel approach utilized
ECM protein (hydrogel) solutions derived from decellularized normal or diseased human
lungs (composition factor) coated onto the surface of CytoSoft® stiffness specific plates (2
kPa, 8 kPa, or 16 kPa) (stiffness factor). Endpoint assessments included cell morphology,
growth, metabolism, and relevant gene expression. These results demonstrate that ECM
composition and substrate stiffness, both alone and in combination affect HLF behavior.

In the second series of studies, the goal was to assess how cyclic mechanical
stretch impact function of an important lung cell type: alveolar epithelial type II (AT2)
cells, critical for surfactant production. Utilizing AT2s derived from induced pluripotent
stem cells (iAT2s) as a model system, the cells underwent biaxial stretch using a
FlexCell® FX-5000™ Tension System for either 2 or 24 hours. Endpoint assessments
included imaging and gene expression compared to un-stretched cells. The results show
unique morphological changes in the stretched samples, while the gene expression data
prove to be more variable.
Collectively, this work shows how environmental and mechanical factors,
including matrix composition, stiffness, and stretch, impact lung cell function and
provides optimized methods to study such interactions. The unique methodology utilized
should enable further investigations into both normal physiology and lung pathologies.
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Chapter 1: Introduction
The current SARS-coV-2 pandemic has put pulmonary health in the spotlight.
However, COVID-19 or SARS-coV-2 disease aside, pulmonary diseases affect a growing
number of individuals. Chronic obstructive pulmonary disease (COPD) and asthma are two
of the most prominent chronic lung diseases that impact millions of people worldwide.
Chronic respiratory disease (including COPD) is the 4th leading cause of death among
adults in the United States, while pneumonia is the leading cause of death in children under
5-years-old, and asthma is the most common disease among children [1 – 3]. More
specifically, approximately 65 million people suffer from COPD, and more than 3 million
people died from the disease in 2017, making it the third leading cause of death that year
[1]. Currently, there are multiple options to alleviate the symptoms of COPD, but few exist
for other devastating chronic lung diseases such as idiopathic pulmonary fibrosis (IPF),
and both COPD and IPF have no cure.
For patients with end stage lung disease facing imminent death, the last treatment
modality often includes allogeneic lung transplantation. Nonetheless, there is a significant
limitation of suitable lung donations, and most patients succumb to their disease while
waiting for a suitable donor. Noteworthy efforts have been made to try to increase the
quantity of viable organs for transplantations, especially with the use of cadaver tissues.
Nonetheless, these efforts do not successfully address the shortcomings in meeting
transplantation needs due to compatibility issues [4]. Thus, there is a considerable need to
investigate bioengineering and regenerative medicine approaches with the goal of producing
functional lung scaffolds that could be useful for transplantation.
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A hallmark characteristic of chronic lung diseases is a pathological change within the
tissue structure, including remodeling, of the lung extracellular matrix (ECM). The ECM
affects both the support structure and the functions and behaviors of cells. As such, it is an
important component to monitor and study in order to gain insight into pathophysiology that
may be occurring. The field of mechanobiology combines engineering principles, biology, and
physics while concentrating on relevant mechanical properties and forces within cells and
tissue structures that ultimately lead to physiological and pathological changes. Within the
broad scope of lung mechanobiology, there are three distinct factors that can be manipulated
during in vitro studies to most closely mimic relevant physiological and pathological milieus:
the ECM chemical composition, the ECM substrate stiffness, and the cyclic forces that act on
cells during the normal expansion and contraction of the lung during breathing.
A proper study design of lung ECM and ECM-cell interactions would need to
incorporate these three inter-related factors. However, this will result in a very complex model
that would generate results difficult to analyze and interpret in a way that would correctly
identify all the interactions and individual contributions. Designing experimental systems that
will allow for such interpretations will be a powerful experimental tool. Thus, throughout this
work, I adopted this approach whenever possible.

1.1. Normal Lung Physiology and Insight into the Alveolar Region
In this section, I discuss normal lung physiology and cellular structures to outline
factors that characterize normal lung function. The respiratory system can be broken into
two general sections: the upper and lower respiratory tracts. The upper respiratory tract
consists of the nose, mouth, pharynx, larynx, and other associated features, while the lower
respiratory tract consists of the trachea, bronchi, bronchioles, and alveoli. During early fetal
2

lung development, branching morphogenesis leads to the development of the trachea, the
largest cross-sectional portion of the conducting airways [4]. The trachea then branches
into two primary bronchi, and they continue to branch off into progressively smaller cross
sections, leading down to the bronchioles and alveoli (Figure 1A).
The cellular structure is characterized by a wide variety of differentiated cells along
the airway tree, as well as epithelial progenitor cells located in different regions. These
latter cells have the capacity to proliferate and differentiate into mature functional airway
cells and thus participate in lung repair after injury [7, 86, 87, 98]. However, dysfunction
of progenitor cells can be seen both in normal aging and different lung disease processes,
and is considered to be a factor leading to chronic lung diseases [7, 86, 87, 98]. One
population of progenitor cells is located at the bronchioalveolar duct junction, and they
have the potential to differentiate into both alveolar type I (AT1) and alveolar type II (AT2)
cells within the lung, two distinct cell populations that are extremely important to lung
physiology [5 – 7]. Directly comparing the two types of cells, AT2 cells are more cuboidal
in shape and greater in number, while AT1 cells are elongated, squamous, and flat [8 – 10].
Regardless, both cells are found at the end of the pulmonary tree in the alveoli, which have
an extremely high surface area to volume ratio and are located after the alveolar ducts.
The overall function of the lungs is to facilitate efficient gas exchange, where O2 is
transported from the alveoli into the tissue, and excess CO2 is removed through expiration
(Figure 1B and Figure 1C). AT1 cells cover 95% of the alveolar surface area and function
primarily to conduct gas exchange across the air-blood barrier (Figure 1C) [9, 10].
Meanwhile, AT2 cells initiate immune responses and produce surfactant to reduce the
surface tension of the lungs and prevent alveolar collapse [11]. AT2 cells also can both
3

self-renew and transdifferentiate into AT1 cells under conditions of environmental or
nutritional stress [7]. That is, AT2 cells have the potential to partake in complete alveolar
epithelium regeneration after injury and are thus a critically important cell in which to
apply novel experimental mechanobiology tools [7]. Thus, there is significant interest in
the ability to control epithelial differentiation and thus to control the fate of these cells.

Figure 1. Schematic of normal lung structure and major cell types present in
alveolar-capillary region. (A) Macroscopic lung depiction showing the trachea, bronchi,
and distal lung regions. (B) Emphasis on air flowing in and out of alveoli. (C) Detailed
cross-sectional view displaying the main cells present within the alveolar-capillary lung
region.

The lungs are also composed of numerous other types of cells, each having their
own contributions to lung structure and function. Lung fibroblast cells are also important
for lung mechanobiology studies because they produce the ECM that gives lungs their
structure, and the ECM remodels significantly during injury or disease. Fibroblasts are also
the most common type of cell found in connective tissue. Furthermore, the ECM also plays
4

a major role in lung elasticity and recoil effects, which are two key function factors for
lungs, making fibroblasts a prominent cell type studied in assessing ECM remodeling.
Lung fibroblasts are also involved in pathology of several lung diseases including COPD
and IPF.

1.2. The Role of Mechanics in Lung Biology
In addition to the chemical and cellular composition of the lungs, mechanics or
mechanical properties, such as airflow pressures, rates, and lung volumes, also play a major
role in lung physiology. Therefore, understanding the forces that are present during normal
breathing is crucial [5, 6]. In vivo, multiple types of mechanical stimuli, such as
compression, tension, hydrostatic pressure, and shear forces are simultaneously acting on
cells [14]. For example, due to cyclic alveolar inflation and deflation, both the lung
endothelium and epithelium experience repeated mechanical stretch [13]. This can be
modeled ex vivo using systems that apply biaxial or equi-biaxial strains [14], where strain
is the deformation or displacement of material that results from an applied stress, and stress
refers to the force applied to a material divided by the material’s cross-sectional area. These
are particularly useful systems in which to study mechanotransduction signaling pathways
where forces are transferred from cytoskeleton to nucleus and can affect gene expression,
so it is important to not only consider cell-cell forces, but also cell-ECM forces. Figure 2
provides a schematic that presents multiple components involved in cell-cell and cell-ECM
interactions, such as focal adhesions, tight junctions, and adherens junctions.
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Figure 2. Major AT2 cell-cell and cell-ECM contacts. Prominent cell-ECM contacts
include focal adhesions, which provide mechanical strength to tissue. Prominent cell-cell
contacts include tight and adherens junctions which determine barrier functions and
polarity of epithelial cells. Adapted from [55].

Many forces are concurrently acting on cells during breathing, and they all play a
critical role in maintaining lung homeostasis, but the work presented here will focus mostly
on the force of mechanical strain. A common range for the normal at rest adult respiratory
rate is 12 – 20 breaths per minute [12]. It is also widely accepted that respiratory rates
above 25 or below 8 breaths per minute are considered abnormal and indicative of patient
deterioration [12]. While these are general ranges, respiratory rates vary greatly from
person to person, due to a wide variety of factors such as age or sex [12].

1.3. Disease Pathogenesis
Lungs are organized and cell function is highly regulated by the physical properties
of the ECM [15]. Thus, monitoring the changes within the lung environment is one of the
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most common ways to determine whether lung structure is transitioning to a diseased state
or has been damaged. The development and progression of disease occurs when cell
function and structure become dysregulated [15 – 17]. More specifically, the milieu with
which a cell is interfacing can provide important biological cues to the regulation of the
mechanical properties that affect cell growth and differentiation, as well as cell migration
and differentiation [15, 18]. This important cell-matrix relationship has led researchers to
pursue stiffness-specific experiments to test the impact of increasing stiffness on cellular
behaviors, including differentiation [19], protein and gene expression [20], and
proliferation [21].
A common method that is employed to analyze biological samples and determine
the protein content is to analyze them using mass spectrometry. This tool often relies on
the analysis of proteolytic peptide mixtures, often referred to as bottom-up proteomics, but
other methods of analyzing longer intact protein peptides, and labeling stable isotopes are
used as well [93]. Regardless of which type of analysis is chosen, the tool fundamentally
relies on measuring the mass-to-charge ratio, and a variety of mass analyzers exist [93].
Recently, more research groups have turned to using mass spectrometry to help answer
lung biology questions and comparing the differences in composition between native lungs
and those that have been decellularized [27, 41, 60, 94 – 96].
Additionally, many methods are employed to measure lung tissue stiffness,
including atomic force microscopy and rheometry. The Young’s or elastic modulus can be
measured and helps classify whether a stiffness falls into a healthy or diseased pathological
range for lung tissue. Substrate stiffnesses between 0.2 kPa – 5 kPa have been commonly
described for healthy lung tissue, while above 10 kPa is often observed in fibrotic lung
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tissue [22 – 25]. Most notably, IPF is often distinguished as an interstitial lung disease
characterized by increased lung stiffness and decreased lung compliance [26], where
compliance refers to the ease with which an elastic structure stretches, or how much the
system changes in volume in response to applied pressure.
Additionally, in patients suffering from IPF, the airspaces enlarge within the distal
portion of their lungs and a distinct honeycomb patterning is often observed on
reconstructed images [56]. Both spatial and temporal heterogeneity is observed in IPF
lungs as many dense fibrotic regions form, and fibroblast foci become evident [56]. There
are several pathologic processes involved in IPF including over production and deposition
of ECM protein, notably collagen, in response to pro-fibrotic stimuli and inflammation, all
of which contribute to increasing tissue stiffness [27 – 30]. In response to inflammation
and other environmental cues, fibroblasts differentiate into pro-fibrotic myofibroblasts,
which express alpha smooth muscle actin incorporated into contractile stress fibers [27 –
30]. The gene of α-SMA or ACTA2 is often used to make determinations about the state
of the lung tissue and is typically used as a myofibroblast marker. Additionally, fibroblasts
have been shown to be responsive to stiffness-sensitive inhibition pathways [24].
Other studies have also shown that epithelial cells often modulate fibroblast
behaviors and can contribute to their response. Epithelial cells are extremely sensitive to
environmental changes, and they release growth factors such as transforming growth
factor-β (TGF-β). TGF-β is an important growth factor to monitor as it mediates fibroblastto-myofibroblast differentiation and is associated with secretion of ECM proteins and
tissue inhibitors of metalloproteinases and promotes matrix-preserving phenotypes [31].
This epithelial-fibroblast relationship needs to be explored further as epithelial cell
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behaviors can directly regulate fibroblasts downstream protein synthesis and changes in
gene expression. Multiple groups have worked to address the question of how lung
fibroblasts change in functional behaviors when grown on different matrix stiffnesses, and
my current work adds to the current knowledge pool [24, 32].

1.4. Selected Cell Signaling Pathways Involved in Mechanotransduction
The Hippo cell signaling pathway plays a significant role in a range of cell
behaviors. Two downstream components that are negatively regulated by the Hippo
signaling pathway are the yes-associated protein (YAP) and transcriptional coactivator
with PDZ-binding motif or taffazin (TAZ). They promote survival and cell proliferation,
regulate differentiation and organ size, and help determine the fate of stem cells, tissue
regeneration, and gene transcription [33, 34]. Existing data suggest a role of static strain
on YAP/TAZ activation including translocation from cytosol to nucleus to affect
transcriptional activities, but this aspect is less explored with cyclical strain (Figure 3) [10,
33 – 35]. Additionally, transmembrane proteins such as integrins are important to study to
better understand how tissue architecture and cell tension regulates YAP/TAZ through the
ECM [34, 36].
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Figure 3. The regulation of YAP by different mechanical stimuli. YAP can be
regulated in both Hippo-dependent and independent pathways and is largely affected by
mechanical changes in the environment of the cell. For instance, Hippo signaling is
inhibited when actin and tension increase and results in YAP dephosphorylation and
nuclear translocation, as well as gene activity. Additionally, the upstream regulator of
LATS1/2 phosphorylates YAP causing cytoplasmic retention of YAP, so when inhibited,
then YAP moves into the nuclear envelope. TAZ typically follows the changes in YAP,
but the understanding of mechanical stimuli effects on TAZ is less understood, so TAZ
was not included as YAP/TAZ. Adapted from [33].

Lastly, it will be important for researchers to consider crosstalk that is occurring
within the cells and consider multiple signaling pathways like the WNT, TGF- β, and Factin pathways when interpreting their results and trying to harvest the potential YAP and
TAZ can have for regeneration with stem-cell based therapies [10, 34]. For instance,
patients suffering from IPF have disrupted cell-cell contacts, so the result of disordered
YAP/TAZ nuclear translocation in the setting of disordered lung stiffness and strain could
open new avenues for potential therapeutic interventions [35, 37]. Finally, drawing
conclusions about YAP/TAZ and the role they have on surfactant production can lead to
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the development of drugs that can improve patient care, as stretch-induced upregulation of
YAP/TAZ also leads to increases in surfactant [36].

1.5. Benefits to Incorporating Decellularized ECM into Culture Systems to
Address Current Limitations of Commercialized Products
There is support from proteomic data that there are 150 different types of proteins,
proteoglycans, growth factors, and enzymes all within the lung that are major ECM lung
components and provide both biomechanical and biochemical signals to the cells within
the matrix [27]. Commercialized products such as Matrigel®, mostly composed of laminin
and derived from mouse tumors, are the most widely utilized substrates for threedimensional (3D) matrix cell culturing [38 – 40]. 3D cell culture techniques are becoming
more popular than conventional two-dimensional (2D) cultures, which typically include
cell monolayers grown on a variety of surfaces, such as tissue culture plastic and protein
coatings. Additionally, 3D cultures often rely on hydrogel matrices and involve spheroid
or organoid growths, which helps them more closely mimic in vivo conditions.
Notably, Matrigel® is commonly used as a scaffold and is composed primarily of
only four basement-membrane proteins, which make-up only a fraction of the proteins
found within the lungs [39, 40]. As the composition of Matrigel® considerably lacks the
full complexity of the lung ECM, there is a significant question as to whether matrices or
hydrogels derived from lung ECM would result in more physiologically relevant cell
culture methods and provide greater insight into cell behaviors that occur in vivo.
Importantly, this would also include ECM hydrogels derived from diseased lung and could
provide a further novel experimental tool with which to study lung ECM cell interactions.
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Decellularized ECM (dECM) has been an underappreciated and underutilized
material within the field of tissue engineering that has recently been gaining traction. To
produce lung dECM, normal or diseased lungs most often undergo a series of washes with
reagents to transform the scaffold into one that is acellular, has minimal residual DNA, but
retains key ECM proteins through a process known as decellularization (Appendix Figure
1) [41 – 44]. Then, the decellularized tissue can be further processed into forms that are
more useable, such as powders or lyophilate, which are useful for a variety of applications
such as hydrogel formation [32, 45 – 48], coating solutions, or bioinks. Current attempts
have only just begun to show success with dECM hydrogels that have been derived from a
variety of tissues, including the work done by one research group producing bladder
hydrogels [99]. For instance, dECM material, including that derived from lung, holds great
promise for both therapeutic applications and analysis of cell behaviors in a more
biologically relevant and high-throughput manner through the creation of worthwhile,
functional, and beneficial long-lasting tissue constructs [49 – 54].
I postulate that dECM hydrogels are particularly suited to assessing
mechanobiology variables, including substrate composition, stiffness, and cyclic strain,
individually and are adaptable to combinatorial designs. This can be a novel means to
address many of the shortcomings of most lung models.

1.6 Overall Significance of Research
Lung dECM holds great promise as a physiologically relevant cell culture
alternative to Matrigel®. Currently, few groups have used human lung dECM hydrogels
to study lung mechanobiology. Furthermore, no one has published using protein coatings
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derived from IPF patients on CytoSoft® stiffness specific plates, which is an approach that
combines two mechanical factors, chemical composition and stiffness. As such, the goals
of my thesis are to develop methodologies to assess and validate that this approach is a
simple and adaptable way to study effects of substrate composition and stiffness on lung
cell behavior using human lung fibroblasts as a model system. I will additionally present
initial studies of the advantages of utilizing this system to study effects of cyclic
mechanical strain and identify useful factors associated with cyclic biaxial stretching that
will be important to incorporate into continued studies. Overall, this work develops new
methodologies that can be used with a range of different lung cell types in follow-up
studies. This proposal is based on the interplay of complex mechanical variables and their
effects on the cell’s environment. Therefore, this research focuses on three variables of
interest for lung physiology, composition, stiffness, and stretch, and works to better understand
their roles in lung homeostasis and disease through mechanical means.

1.7. Thesis Outline
In this thesis, two series of studies will be described, each within their own
chapter, that highlight new in vitro lung cell model methodologies utilizing ECM
material. Chapter 2 will focus on how the variables of stiffness and composition interact
to trigger changes in HLF cells and subsequently lead to a diseased state. Chapter 3 will
focus on variables related to cyclic mechanical stretch and how biaxial strain impacts
type II alveolar epithelial cell function, with a focus on surfactant secretion. Each chapter
is structured with a brief introduction, followed by objectives for the study, and approach
and methods sections. Then, the results and discussion follow. Lastly, each chapter ends
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with conclusions and future directions. Finally, Chapter 4 provides overarching
conclusions and considerations for future directions.

14

Chapter 2: Stiffness and Composition
2.1. Introduction
2.1.1. Background
The structure-function relationship of tissue is a pivotal concept to understand and
investigate as it provides a significant amount of information on the various components
involved in lung homeostasis and changes that occur due to disease pathogenesis. For
individuals suffering from chronic fibrotic diseases, tissue remodeling is a hallmark
characteristic [61, 62]. More specifically in IPF lungs, increases in localized tissue stiffness
leads to heterogenous properties [26 – 30, 56]. Fibroblasts are a major cell population that
undergoes changes in function as the tissue stiffness becomes pathological, and they begin
to differentiate into myofibroblasts to promote wound healing [32]. Researchers have also
been able to isolate a smaller subpopulation of activated fibroblasts in fibrotic tissue that
resists apoptosis through a mechanism that is largely unknown [63, 64]. Therefore, there
is significant need to better understand the signaling pathways involved and determine the
role of the matrix modulus on cell signaling so steps can be taken to potentially reverse or
delay the changes in fibroblast phenotype for therapeutic treatments and tissue regeneration
strategies [32, 65].
Whereas great strides have been made to characterize the effects of stiffness on
fibroblast cells cultured on collagen coatings [23, 24, 37, 61], fewer studies have been done
using dECM hydrogel coatings [32, 45, 60] leaving a gap in knowledge. Therefore, a
critical need exists for studies assessing the changes in fibroblast function when cultured
on dECM, and how they respond when factors, such as stiffness and chemical composition
of dECM are modified [21, 23, 24, 28, 37, 61]. This is one major goal of this thesis.
15

As previously stated, Matrigel® is extensively used as a scaffold in cell culture
studies. Unfortunately, its use has several disadvantages. For instance, the composition of
Matrigel® is not able to recapitulate the full complexity of lung tissue as far as chemical
composition and there is significant batch-to-batch variability. Therefore, results assessing
cellular responses must be interpreted with caution. Finally, the physical and biochemical
properties are not conducive to easy manipulation [38 – 40]. Hence, using dECM in in vitro
cell culture studies will not only address many of the limitations and concerns of Matrigel®
[46, 53, 66], but will also allow for mimicking chemical composition and stiffness of both
physiological and pathological lung milieus.
Methods exploring a variety of protein coatings, most notably those on PAA and
tissue culture plastic, have been described [15, 21, 37, 90, 91, 92]. However, we are
unaware of any use of either healthy- or diseased-derived human lung dECM in studies
assessing effects of stiffness or dECM chemical composition, in combination. To achieve
this design, one can use dECM protein coatings on silicone substrates with modulated
stiffnesses. Describing how this methodology was accomplished, as well as how it affects
fibroblast cell function are other major goals of this thesis.

2.1.2. Preliminary Studies
The concepts for the work described in this thesis arose from preliminary data I
collected using a slightly different model system. In that experiment, lung dECM or
collagen I coatings (0.1 mg/mL) were added to polyacrylamide (PAA) hydrogel substrates
with distinct stiffnesses (5, 13, and 30 kPa) and HLF cellular viability and metabolism were
assessed with PrestoBlue™ (Thermo Fisher Scientific, MA, USA, cat. #A13262). The
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dECM used was derived either from healthy or COPD patients and Sulfo-SANPAH
(Sigma, MO, USA, cat. #803332) was used as part of the coating process. On the 5 kPa
PAA hydrogels, there was a significant decrease in cellular metabolism on day 5 in the
HLF cells on COPD coatings, when compared to healthy control, but not collagen I
coatings (p < 0.0005) (Figure 4A). Additionally, there was a significant decrease in HLF
cellular metabolism when cells were cultured on COPD coatings of 13 kPa hydrogels on
days 3 and 5, when compared to healthy controls, but not on collagen I coatings (p < 0.05
and p < 0.005 respectively) (Figure 4B). However, there were no significant changes when
cells were cultured on the 30 kPa hydrogels, regardless of coating type (Figure 4C), which
could be attributed to a ceiling effect of stiffness that may have occurred. Importantly, these
results initiated the development of the methods presented in this thesis chapter, which will
parse out the effects stiffness and composition have, individually and in combination, on
representative cellular behaviors (i.e., proliferation and metabolism).
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Figure 4. Cell metabolism absorbances of HLF cells cultured on substrates with
different stiffnesses and chemical compositions. (A) Cell proliferation decreased on
day 5 when cultured on COPD vs. healthy coatings on 5 kPa PAA hydrogels. (B) Cell
proliferation decreased on days 3 and 5 when cultured on COPD vs. healthy coatings on
13 kPa PAA hydrogels. (C) There were no effects of coating type on cell proliferation
when cells were cultured on 30 kPa PAA hydrogels. (N=3, mean ± SEM, ANOVA).

A major modification I made in the method from the preliminary study was
eliminating the PAA hydrogel, which has been shown to have cytocompatibility issues and
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can undergo drastic degradation [57]. Additionally, COPD dECM was replaced with IPF
dECM, and the stiffnesses changed from 5, 13, and 30 kPa to 2, 8, and 16 kPa, which are
more relevant for IPF [22 – 25]. I also assessed cell metabolism for a total of seven days to
assess both log phase active growth and metabolism, as well as to observe whether a plateau
occurs when cell monolayers become confluent. Finally, I included an emphasis on HLF
gene expression, which should help depict a more complete picture of the biological
changes in HLF cells when chemical composition and stiffness change.

2.1.3. Objectives
The goal of this work was to develop and optimize a novel cell culture methodology
that integrated the mechanical factors of dECM chemical composition and surface stiffness
to study their effects on lung cell function. Furthermore, the goal was to also produce a
method that could be easily tailored to better reflect both in vivo normal and pathological
lung function. As such, human healthy lung-derived dECM was incorporated into this
study to act as a proof of concept and reference, while human IPF lung-derived dECM was
utilized as a disease model to gain insight into the pathogenesis. The overarching
hypothesis, therefore, was that dECM composition and stiffness interact to influence HLF
metabolic activity and gene expression. The four specific aims were:
1. To optimize a coating method that allowed for dECM to bind to a silicone
membrane.
2. To further assess the variation of stiffness and protein composition between normaland IPF-derived human lung dECM.
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3. To conduct in-vitro studies using HLF cells cultured on both healthy- and IPFderived dECM protein coatings while modulating the surface stiffness.
4. To determine the effects of healthy- and IPF-derived dECM on HLF gene
expression.

2.2. Approach and Methods
2.2.1. dECM Lyophilate Generation
Two sets of cadaver lungs were obtained from autopsy (courtesy of UVM autopsy
services). One set of lungs was from a healthy patient with no lung disease or history of
smoking, and the other from a patient diagnosed with IPF. The whole lungs underwent
decellularization and assessment using published protocols [41, 58 – 60]. In short, the lungs
were rinsed with phosphate buffered saline and then deionized water six times each to
remove excess blood. Next, the lungs were perfused with various solutions alternating
between airway and vasculature (3 times each, ~2 L in total for each solution) using a
peristaltic roller pump (Multiflow Roller Pump 10-00-00, Stockert Shiley, SOMA
Technology, CT, USA). The solution sequence was as follows: 0.1% Triton-X 100 (Sigma,
cat. #X100), 2% sodium deoxycholate (Sigma, cat. #D6750), 1M sodium chloride (Fisher
Scientific, NH, USA, cat. #S671-500), 30 μg/mL DNase (Sigma, cat. #DN25), and 0.1%
peracetic acid (Sigma, cat. #269336). After, a final distilled water wash, the lungs were
stored in distilled water until they were dissected. The efficiency of decellularization was
assessed by measuring residual DNA in decellularized versus native tissue and assessing
lung cellular structure following standard hematoxylin and eosin staining.
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Figure 5. Schematic outlining flow of experimental methods.

The decellularized lung tissue was next processed using standard techniques, as
depicted in Figure 5 (Hoffman et al., paper in preparation). In summary, the bulk tissue
was lyophilized (Labconco, MO, USA, cat. # 7670521) and subsequently milled in liquid
nitrogen (Freezer Mill, Spex, NJ, USA) to produce a dECM powder (Figure 5B). Next,
the dECM powder (10 mg/mL) was pepsin digested (1 mg/mL (Sigma, cat. #P6887) in
0.01 M hydrochloric acid (Fisher Scientific, cat. #02-003-038) solution) for 72 hours at
room temperature with constant stirring, which was done with specialized stir bars (V&P
Scientific, Inc., CA USA, cat. #VP 782N-12-150) (Figure 5B). The stir bar was then
removed, and the solution was centrifuged at 2700 rpm for 10 minutes (Allegra™ 6R
Centrifuge, Beckman Coulter, IN, USA) to pellet out the insoluble fraction (Figure 5C).
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The supernatant was transferred into a new test tube and kept on ice until it was
slowly titrated with 0.1 M sodium hydroxide (Fisher Scientific; 1/9th the total volume of
the dECM supernatant) while vigorously mixed to prevent aggregate formation. The
addition of the sodium hydroxide changed the pH of the acidic solution to approximately
neutral (7 – 7.4), which was subsequently confirmed with pH strips (Micro Essential
Laboratory Inc., NY, USA, cat. #6080). The neutralized solution was then frozen at -80ºC
and lyophilized (Labconco) for 24 hours (Figure 5D). Lyophilate was stored at -20ºC until
it was used to prepare coating solutions.

2.2.2. Preparation of Coating Solutions
For each type of coating solution (IPF- or healthy-derived), dECM lyophilate was
resuspended in ice cold 0.02 M sterile acetic acid to create a 2 mg/mL intermediate stock
solution (Figure 5E). This solution was kept on ice overnight to achieve complete resolubilization of the protein. After homogenization using a pipette, it was then further
diluted to a final concentration of 0.1 mg/mL with sterile PBS (Thermo Fisher Scientific,
cat. #10010049, pH=7.4) and the final pH was ~6.8 (Figure 5F and 5G).

2.2.3. Cell Culture Methods
Normal primary human lung fibroblast (HLF-CCD19Lu, ATCC® CCL-210,
ATCC®, VA, USA) cells were cultured in minimum essential medium (Thermo Fisher
Scientific, cat. # 11095080) supplemented with 10% fetal bovine serum (HyClone™,
Cytiva, MA, USA) and 1% penicillin/streptomycin (Thermo Fisher Scientific, cat.
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#15140122), and they were kept in a humidified incubator (5% CO2, 37°C, Thermo Fisher
Scientific, cat. #3110). HLF cells were used in experiments at passage 5. TrypLE™
Express Enzyme (Thermo Fisher Scientific, cat. # 12605010) was used to dissociate the
cells from the flask. Then, the cells were centrifuged (Allegra™ 6R Centrifuge, Beckman
Coulter) at 1200 rpm for 5 minutes to form a cell pellet. The cell pellet was then
resuspended in HLF media and counted on a hemocytometer (Thermo Fisher Scientific,
cat. #0267151B). For the experiments, 2 x 105 HLF cells/well were used (Figure 5J).

2.2.4. Coating the CytoSoft® Plates
Six-well plates, either CytoSoft® (2, 8, and 16 kPa stiffnesses, Advanced
BioMatrix, CA, USA) or standard cell culture tissue treated plastic plates (Fisher Scientific,
cat. #FB012927) were used as depicted in Figure 6. The 0.1 mg/mL coating solutions were
allowed to come to room temperature for 1.5 hours, and then 3 mL of the respective
solutions were added to each well (Figure 5H). The wells were incubated for 1.5 hours
and then the coating solution was aspirated. Each well was then rinsed with ~1 mL of PBS
(Thermo Fisher Scientific, cat. #10010049, pH=7.4) twice and 2 mL of HLF media
containing 2 x 105 HLF cells was added (Figure 5I).
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Figure 6. CytoSoft® plates of different stiffnesses or tissue culture plastic plates
were coated with either healthy- or IPF-derived dECM. The final data are obtained
from three replicates of this design.

2.2.5. Endpoint Analyses
Several dependent variables were measured. First, phase contrast imaging
provided qualitative information about general cell health, density, and growth by
monitoring the cell morphology and spatial arrangement. Secondly, cellular metabolism
was monitored using the PrestoBlue™ assay (Thermo Fisher Scientific, cat. #A13262).
Both imaging and PrestoBlue™ assays were done every 48 hours to observe significant
changes in the samples, while reducing potential environmental stress that daily
measurement would have created. Moreover, daily measurements could have led to
removal of the coating due to the necessary washes during the procedure. Finally, cells
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were collected on days 3 and 7 after the PrestoBlue™ assay was done and RNA was
extracted from these cells to evaluate gene expression. Day 3 was, based on qualitative
imaging assessment, a time point when cells had adjusted to their environment after being
seeded on day 0. Additionally, Day 7 was chosen since it was the last day of the
experiment and we were seeking to compare this with an earlier, intermediate time point
(Day 3).

2.2.6 HLF Cell Morphology
To monitor cell morphology, phase contrast imaging was done on days 1, 3, 5,
and 7 using a 4X objective on an inverted microscope (AMG EVOS, Model AME-3206)
(Figure 7A), and then images were processed in ImageJ (Version 1.53j, National Institutes
of Health). It was expected that the HLF cells would be attached to the coatings and
elongated. Additionally, the presence of rounded and floating cells or debris were noted.

Figure 7. Experimental timeline and representative plate layout used to assess
changes in cell morphology and viability, cell metabolism and gene expression. A)
Depicts experimental timeline utilized for this study while B) showcases a typical 6 well
plate that corresponds to the wells identified within the timeline.
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2.2.7 Analysis of HLF Cell Viability and Metabolism
HLF cell viability and metabolism were assessed by measuring fluorescence of
the media on days 1, 3, 5, and 7 using the PrestoBlue™ assay. Cells were incubated in a
10% v/v solution of PrestoBlue™ reagent (Thermo Fisher Scientific, cat. #A13262) in cell
culture media for 1.5 hours in a sterile humidified incubator (5% CO2, 37°C), and protected
from light. Pipetted triplicates of 100 μL were then transferred from the 6-well plates into
a 96 well plate (CytoOne®, USA Scientific) along with media blanks. The plates were then
read on a Synergy™ HT (BioTek Instruments, Inc., VT, USA) plate reader at 560 nm
excitation and 590 nm emission and resulted in fluorescence readings.
Data were analyzed utilizing Excel version 16.48. First, the fluorescence triplicate
readings for each sample were averaged and then the average fluorescence readings of the
media blanks were subtracted from each averaged experimental fluorescence value. This
process resulted in what was referred to as the adjusted experimental fluorescence reading.
Then, to adjust for cell proliferation, on each day of the experiment (days 1, 3, 5, and 7)
the adjusted experimental fluorescence readings for the plastic tissue culture plates had the
adjusted experimental fluorescence readings of the CytoSoft® plates subtracted from it. A
total of 9 data points per experimental condition were analyzed and presented in graphs as
means ± SEM. It is important to note that a small, normalized fluorescence value means
that the difference between the metabolic activity of the HLF cells on CytoSoft® plates
was very similar to the metabolic activity of the HLF cells on plastic plates, which is known
to produce higher cell metabolisms.
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2.2.8 Analysis of HLF Cell Phenotype
2.2.8.1 RNA Isolation
On days 3 and 7, HLF cells were harvested for RNA isolation. Media from each
well was aspirated and 1 mL of TrypLE™ Express (Thermo Fisher Scientific, cat. #
12605010) was added to each well. The plate was then placed in the sterile humidified
incubator (5% CO2, 37°C) for 5 – 10 minutes, at the end of which, the solution now
containing the floating cells was transferred to separate Eppendorf tubes. Samples were
then centrifuged (Allegra™ 6R Centrifuge, Beckman Coulter) at 1200 rpm for 5 minutes.
The cell pellet was then resuspended in 350 μL of RLT buffer (Qiagen) and frozen at 80°C.
When all samples were collected, RNA was extracted using the RNeasy Mini Kit
(Qiagen, cat. #74106) according to the manufacturer’s protocol. Briefly, an equal volume
of 70% ethanol was added to the sample in RLT buffer, and after thorough pipetting, the
solution was transferred into the spin columns provided by the kit and the columns were
centrifuged (Eppendorf Centrifuge 5424) at 8000 rcf for 30 s. The flow through was
discarded and 700 μL of buffer RW1 was added to the RNeasy spin column. After
subsequent centrifugation at 8000 rcf for 30 s, the flow through was discarded again and
500 μL of RPE buffer was added to the columns. The next centrifugation step at 8000 rcf
for 30 s was done once more. The next centrifugation step was 2 mins long and it ensured
that the columns were free of remaining RPE buffer. An optional step was then completed,
where the spin columns were placed into a new 2 mL collection tube and centrifuged at
maximum speed for 1 min as this step helped dry the membrane. Then, the spin columns
were individually transferred to a 1.5 mL collection tubes that were provided and 30 μL of
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RNAse-free water was directly added to the spin columns. Again, the tube was centrifuged
(Eppendorf Centrifuge 5424) for 1 min at 8000 rcf. This resulted in an eluate being
collected within the 1.5 mL collection tube and is referred to as the final isolated RNA
sample.
Subsequently, the RNA samples were kept on ice and the RNA concentration was
quantified using the Nanodrop™ (Thermo Fisher Scientific), according to standard
protocol.

2.2.8.2 cDNA Synthesis by Reverse Transcription
RNA samples (~300 ng) were reverse transcribed into cDNA using the iScript™
cDNA Synthesis Kit (Bio-Rad, CA, USA, cat. #1708891) according to the manufacturer’s
protocol. Briefly, several kit reagents (Appendix Table 1) were mixed and run on a
C1000™ Thermal Cycler (Bio-Rad) using the protocol outlined in Appendix Table 2.
Afterwards, the cDNA was diluted with RNA free water 1:3, bringing the total volume to
60 μl, and the samples were stored at -20°C.

2.2.8.3 Quantitative PCR (qPCR)
qPCR gene expression assays were done using the iTaq Universal SYBR® Green
Supermix (Bio-Rad, cat. #1725125) kit and MicroAmp® Optical 384-Well Reaction plates
(Applied Biosystems, MA, USA, cat. #4309849). Five ng/μL cDNA was used with the
master mix and primers listed in Appendix Table 3 and the reaction conditions listed in
Appendix Table 4. Both positive and no template controls were added to each plate and
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were tested for each gene. The positive control was cDNA from human lungs. All primers
were purchased directly from Integrated DNA Technologies (IDT, IA, USA) and the
sequences for these genes can be found within Appendix Table 5.
Only the data that had clear melt curves, identified by one amplified peak as
generated by the qPCR software analysis program, were used. For the analysis, all CTvalues of the pipetted duplicates were averaged. Then, the relative transcript abundance of
a gene was calculated using the standard ΔΔ CT method. For example, the average Δ CTvalue of HLF cells on IPF coatings from the plastic plates was subtracted from the Δ CTvalues of HLF cells on IPF coatings from the CytoSoft® plates.

2.2.9. Data and Statistical Analyses
All PrestoBlue™ data were assembled in Excel version 16.48 and statistical
analyses and graphs were generated with GraphPad Prism 8.2.1. All experiments had three
technical replicates for each end point analysis, which were averaged. Since the experiment
was repeated three times, the final number of data points per condition group was 9. For
statistical analyses, data was first checked to confirm that the assumptions (normality and
equal variance) for parametric analyses were met. This was done using the AndersonDarling and Brown-Forsythe tests, respectively. When data failed these assumptions,
outliers, if any, were removed using the Median Absolute Deviate test [100]. In total, 2
outliers were removed, all of which were from cells cultured on IPF-derived coatings and
tested on day 7. Since data then met the assumptions for parametric analyses, 3 x 4 twoway ANOVA procedure were used (3 different stiffnesses and 4 different dECM coating
types as factors) and the differences between means were analyzed with the Hochberg
28

variation of the Bonferroni post hoc tests. The Hochberg variation allowed us to test only
comparisons of interest while controlling for multiplicity that provided the necessary
statistical power by preserving the type I error rate throughout. In graphs, a p-value lower
than 0.001 is represented by ***, a p-value lower than 0.01 is represented by **, and a pvalue lower than 0.05 is represented by *. Lastly, all PrestoBlue™ values are shown as
mean ± SEM within graphs.
A similar approach was taken for the qPCR data. Unfortunately, the assumptions
for parametric analyses were not met, so non-parametric analyses were used. As such,
Mann-Whitney tests were used to check for significance between groups. All gene
expression fold change values are graphed as median ± IQR.

2.3. Results and Discussion
2.3.1. Results
2.3.1.1 dECM Coatings are Necessary for Cell Attachment and Survival when
Cultured on CytoSoft® Plates: Proof of Concept
Figure 8 allows for direct qualitative comparisons across different types of plates
to determine the effects of the protein coatings, prepared with the new, improved method,
on cell survival. Utilizing a CytoSoft® plate of 0.2 kPa stiffness for initial assessment,
Figure 8 demonstrates that a dECM coating was required for cells to adhere and remain
viable when cultured on CytoSoft® plates. No HLF cells survived or were visible after 72
hours on the uncoated CytoSoft® plate (Figure 8A). Similarly coated tissue cultured
plastic wells were used as a positive control (Figure 8C).
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Figure 8. Phase contrast images showing cell attachment after 72 hours in wells with
and without dECM coatings. (A) No coating on CytoSoft® plate. (B 0.1 mg/mL
healthy dECM coating on CytoSoft® plate. (C) 0.1 mg/mL healthy dECM coating on
tissue culture plastic plate. Scale bar = 1000 μm.

2.3.1.2 HLF Cells Show Similar Viability when Cultured on Either Healthy- or
IPF-derived dECM Coated- CytoSoft® Plates, Regardless of the Stiffness of the
Plate
After confirming that dECM protein coatings are necessary for cellular
attachment and growth on CytoSoft® silicone membranes, the final experiments assessing
how composition and stiffness may affect cell attachment, growth, and viability began.
Qualitative observations were first performed. Figure 9 shows representative phase
contrast images of the 2 kPa CytoSoft® plates compared to those on tissue culture plastic,
which acted as our positive control. Figure 10A, 10B, and 10C respectively depict
representative phase contrast images of the HLF cells on the 2 kPa, 8 kPa, and 16 kPa
CytoSoft® plates with healthy- or IPF-derived dECM coatings.
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Figure 9. Representative phase contrast images taken with 4X objective on days 1, 3,
5, and 7 showing HLF cell growth on 2 kPa CytoSoft® plate compared to tissue
cultured plastic plates coated with both healthy- and IPF-derived dECM. Scale bar =
1000 μm.
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Figure 10. Representative phase contrast images taken with 4X objective on days 1,
3, 5, and 7 showing HLF cell growth on CytoSoft® plates with healthy- or IPFderived dECM. (A) 2 kPa representative of healthy stiffness, (B) 8 kPa representative of
pre-fibrotic stiffness, (C) 16 kPa representative of fibrotic lung stiffness. Scale bars =
1000 μm.
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2.3.1.3 dECM Coating Composition Significantly Influences HLF Cell Metabolism
Following imaging, we investigated whether the composition of the dECM
coating (i.e., whether derived from healthy or IPF tissue) differentially influenced the cell
metabolic activity. Two-way ANOVAs, performed as described above, were followed up
with post-hoc comparisons of healthy vs. IPF within each stiffness factor, across days. Data
is shown in Figures 11 – 13. Overall, the trend was that IPF-derived coating led to a
decrease in HLF metabolic activity. Significant changes in relative fluorescence units were
not noted for each time point across the three stiffnesses, potentially suggesting that
stiffness does not interact significantly with the coating type to influence cell activity.
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Figure 11. Metabolic activity of HLF cells cultured on 2 kPa CytoSoft® plates
normalized to cells cultured on plastic significantly decreased in the HLF cells on
IPF-derived coatings on days 1, 3, and 5. These results suggest that a smaller relative
fluorescence unit value means that the cell metabolism within the condition was high
since the difference between the plastic and CytoSoft® condition was minimized and
HLF cells had the highest metabolism when cultured on plastic. (N=9, mean ± SEM, **p
< 0.01, ***p < 0.001).
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Figure 12. Metabolic activity of HLF cells cultured on 8 kPa CytoSoft® plates
normalized to cells cultured on plastic significantly decreased in the HLF cells on
IPF-derived coatings on day 5. These results suggest that a smaller relative fluorescence
unit value means that the cell metabolism within the condition was high since the
difference between the plastic and CytoSoft® condition was minimized and HLF cells
had the highest metabolism when cultured on 16
plastic.
kPa(N=9, mean ± SEM, ***p < 0.001).
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Figure 13. Metabolic activity of HLF cells cultured on 16 kPa CytoSoft® plates
normalized to cells cultured on plastic significantly decreased in the HLF cells on
IPF coatings on days 3, 5, and 7. These results suggest that a smaller relative
fluorescence unit value means that the cell metabolism within the condition was high
since the difference between the plastic and CytoSoft® condition was minimized and
HLF cells had the highest metabolism when cultured on plastic. (N=9, mean ± SEM, **p
< 0.01).
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2.3.1.4 CytoSoft® Plate Stiffness Affects HLF Cell Metabolism when Cells are
Cultured on IPF-derived coating
To determine if increases in stiffness influence the HLF cell metabolism, we
compared the means of different stiffnesses within each coating (i.e., either healthyderived or IPF-derived dECM). We did not see any significant differences in the effect
of stiffness on cell metabolism when cells are cultured on healthy-derived dECM
coatings (Figure 14A). However, on day 3, the IPF-derived coating elicited an increase
in cell metabolism as the stiffness increased (Figure 14B).
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Figure 14. Metabolic activity results from days 1, 3, 5, and 7 of HLF cells on all
CytoSoft® plates that were normalized to plastic. (A) HLF cells on healthy dECM
coatings and (B) HLF cells on IPF dECM coatings that indicate significantly higher cell
metabolism on the 16 kPa substrates and a similar upward trend on day 5. These results
suggest that a smaller relative fluorescence unit value means that the cell metabolism
within the condition was high since the difference between the plastic and CytoSoft®
condition was minimized and HLF cells had the highest metabolism when cultured on
plastic. (N=9, mean ± SEM, **p < 0.01).

2.3.1.5 Gene Expression
qPCR assays were used to show gene expression and fold changes in mRNA
levels from day 3 and day 7 samples. Several genes were monitored, and the fold changes
were normalized to the plastic controls. The effects of coating composition and stiffness
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are shown in Figures 15 and 16, respectively. We detected no statistical difference in
gene expression for any stiffness or either coating.
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Figure 15. Relevant HLF target gene expression on days 3 and 7 grouped by
stiffness. (A) Col1A1, (B) ACTA2, (C) YAP, (D) TAZ, (E) TGFB1, (F) TIMP1, (G)
Casp3, and (H) Ki67. (N=9, median ± IQR).
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Figure 16. Relevant HLF target gene expression on days 3 and 7 grouped by
composition. (A) Col1A1, (B) ACTA2, (C) YAP, (D) TAZ, (E) TGFB1, (F) TIMP1, (G)
Casp3, and (H) Ki67. (N=9, median ± IQR).

2.3.2. Discussion
Being able to manipulate the variables of stiffness and matrix composition into
experimental designs is pivotal in understanding the true complexity of in vivo cellular
behaviors in the lung. With the growing interest in producing more representative and
physiologically relevant model systems, the need for simple and adaptable
methodologies is greatly needed in the field. The results presented above demonstrate
that it is possible to add matrix composition and stiffness factors into the design through
dECM protein coatings synthesized from digested and neutralized lung lyophilate that
was applied on CytoSoft® plates that had variable stiffness membranes. The cells adhere
and survive well and appear healthy over a period of up to 7 days. This is clear proof of
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concept and can be used in future studies. Moreover, this technique is easy to establish
and leads to more consistent results than, for example, polyacrylamide gels or some other
functionalized hydrogel surfaces.
It is worth noting that this method differs from the established Advanced
BioMatrix protocol. The commercialized CytoSoft® plates were designed and validated
by the company with single protein compositions, not more complex compositions such
as those provided by the dECM coatings used in this study. The results presented here
validate that a slightly acidic (pH ~6.5 – 6.8) dECM lung coating solution can bind to the
membrane and facilitates cell attachment with high biocompatibility. As shown in Figure
8, a protein coating solution was required for cell adherence and the dECM coating was
able to achieve similar results between the CytoSoft® plates and the standard plastic
tissue cultured plates.
An advantage of the coating technique demonstrated here is that the dECM
lyophilate was pepsin digested prior to making the coating solution. This is important as
it isolates the soluble fraction of proteins and leads to a more homogenous and consistent
coating solution with minimal protein aggregates. Moreover, this enzymatic digestion
step helps get large and typically difficult proteins, such as triple helix collagen, into
solution while balancing the overall number of proteins that were useable and present.
Resuspending the lyophilate in an acidic solution at an intermediary concentration, and
then further diluting with PBS improved re-solubilization efforts and enabled pH
adjustments to be compatible with the silicone membranes and cells.
To our knowledge, this is the first study showing that lung dECM derived from
human patients can be used in combination with CytoSoft® plates. We further present
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evidence that the type of coating (i.e., healthy- and IPF-derived) and the stiffness of the
membranes influence the cellular metabolism and gene expression when HLF cells are
used.
We first assessed any changes in cell morphology. Using phase contrast imaging,
we obtained qualitative cell morphology data, such as spatial arrangement, general
health, and the confluence of the cells within the wells. Figures 9 and 10 clearly show
that coatings supported cell growth and proliferation, and there were no obvious
differences between HLF confluence or morphology between the healthy and IPF
coatings which was seen across all CytoSoft® stiffnesses. Interestingly there was strong
evidence that HLF cells proliferated and reached 100% confluence faster on the plastic
plates in comparison to the CytoSoft® plates, and this was again consistent across all
CytoSoft® stiffness plates (2 kPa, 8 kPa, and 16 kPa). The rate of reaching confluence is
an important finding to note, but it was not detrimental to the experimental design. The
plastic tissue culture plates with each type of coating were included to act as a control
and were used to normalize the results from the CytoSoft® stiffness plates.
This experimental design also focused on drawing conclusions on cell
morphology of HLF cells when they were cultured on the same stiffness plates, but on
different coatings, or on the same coating but across a range of stiffnesses. Based on the
qualitative results from imaging, there were no obvious differences in HLF morphology
or growth between the healthy- and IPF-derived dECM protein coatings when stiffness
was held constant (Figure 10), or when the HLF cells on 2 kPa plates were compared to
HLF cells on the higher stiffness plates (8 kPa or 16 kPa). This can be seen if comparing
Figure 10A to Figure 10B, or Figure 10A to Figure 10C, respectively. However, once
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the quantitative data was collected and analyzed, the findings became more
comprehensive and showed distinct differences.
Measurement of cell metabolism using the PrestoBlue™ assay pointed to a
decreased difference in cell metabolism normalized to plastic from the HLF cells on IPFderived protein coatings compared to the healthy-derived protein coatings, especially
across days. The presented relative fluorescence values were calculated by subtracting
the fluorescence value of HLF cells cultured on CytoSoft® plates from the fluorescence
value of HLF cells cultured on plastic plates. HLF cell metabolism was greatest when
cultured on plastic, therefore, a small relative fluorescence value means that the
metabolism within that condition was high as both the minuend and subtrahend were
large, so caution should be employed when interpreted the results of all PrestoBlue™
figures.
Figure 11 shows that there is a trend for a greater difference between the means
on days 5 and 3, but this was not tested statistically. This suggests that, with time, the
matrix compositional effects may gradually affect the HLF metabolism more. This trend
does not hold true on day 7, however, this can be attributed to the fact that the HLF cells
were no longer in log phase growth and had reached confluence, at which point their
behavior may be altered. Additionally, the HLF cells regardless of condition were most
confluent on day 7 and qualitatively any differences between conditions (CytoSoft®
versus plastic) were minimal, so it is to be expected that that the overall PrestoBlue™
values on day 7 were lower than the previous days, as seen consistently in Figures 11 –
13.
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Figure 14 shows that the HLF metabolism of cells cultured on healthy-derived
dECM protein coatings did not differ across stiffnesses on each day, and there were no
statistically significant findings. Again, data from day 7 (Figure 14A) should be
interpreted with caution but shows an upward trend in metabolism results as stiffness
increases. On day 7, the cells were not as actively proliferating due to confluence, so a
reasonable postulation is that an additional energy consuming process could be stiffness
dependent and having more of an impact on metabolism. While it is likely that
proliferation was a major contributor of the cell metabolism across days 1 – 5, it is
unlikely significant proliferation was occurring on day 7. Figure 14B shows a
statistically significant increase in calculated relative fluorescence values as stiffness
increases on day 3 for HLF cells cultured on IPF-derived dECM protein coatings. This
means that the HLF cell metabolisms were lower when cultured on the higher stiffness
plates (e.g. 16 kPa plate compared to the 2 kPa plate) since the difference between plastic
and CytoSoft® plates resulted in a larger normalized value. The metabolism was greatest
in the HLF cells on the 2 kPa plates. This suggests that the cells are more metabolically
active when cultured on a softer substrate and on IPF dECM coatings on days 3 and 5
(Figure 14B).
The second type of quantitative data is gene expression values obtained from
qPCR assays. A wide range of target genes was assessed on days 3 and 7 from the various
conditions. It should be noted that the marker for proliferation, Ki67, was not included
for the day 7 mark (Figure 15H). The amplification plots were variable, and the melt
curves did not have one distinct peak for these samples, which ultimately meant this data
was not interpretable. The variable melt curves are indicative of very low gene expression
42

and suggestive of minimal proliferation on day 7. It can be ruled out that this result was
caused by other issues such as contamination, cDNA quality, or primer incompatibility
since both the cDNA samples worked perfectly with other genes, the samples from day
3 worked well with the same primer solutions, and the negative wells had insignificant
amplification, less than 1%.
Although there were no significant differences between the medians, one
noteworthy trend was in YAP expression. There is an upward trend in gene expression
as stiffness increases on day 7 in the healthy samples (Figure 16C), which is consistent
with previous findings [34, 88]. Additionally, Figure 16C shows YAP expression is
upregulated across all stiffnesses on day 7 in cells cultured on healthy- and IPF-derived
coatings. This is an interesting finding because high cell density has been shown to
inactivate YAP [89], which suggests that the cell signaling pathway is being activated
through an alternate mechanism than the cell-cell interaction, which typically inhibits
LATS1/2 and causes YAP cytoplasmic retention [33].
Similarly, TAZ tends to be upregulated in all samples on days 3 and 7, but has a
median that is much greater in cells grown on IPF-derived coatings in 16 kPa stiffness
wells (Figure 16D). The expression of TGFB1, which is an inflammatory marker, is
upregulated slightly in cells cultured on IPF-derived coatings on 2 kPa or 8 kPa wells
(Figure 16E). Additionally, Figure 16F shows an upward trend in samples on day 3 in
cells cultured on both healthy- and IPF-derived coatings, which starts decreasing by day
7. The several interesting trends in these data suggest that both the stiffness and
composition can play a crucial role in gene expression in HLF cells, but more work needs
to be done, with perhaps higher sample numbers, to draw conclusive remarks.
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2.4. Conclusion and Future Work
2.4.1. Conclusion
The results presented in this chapter suggest that this method can be used to
identify changes in both cellular metabolism and gene expression when the variables of
stiffness and composition are modulated. This method is adaptable, simple, and utilizes
dECM material for protein coatings which can have greater impact when determining
changes in both physiological and pathological cell function in the lung. A relevant cell
type was used as a positive control to demonstrate that this model is scientifically useful.
The data supports that the HLF cells remained viable and changed their cell metabolism
across days. While it is difficult to draw clear conclusions from imaging and the qPCR
results, the significant decrease in relative fluorescence values for HLF cells on IPFderived coatings is encouraging, as it potentially suggests that the composition is directly
impacting the cell metabolism and leading to increased cell metabolism of HLF cells when
cultured on an IPF dECM coating. Overall, this method adds a way to use mechanobiology
factors to identify changes in cell function in a variety of experimental designs [24, 32, 37,
61, 62, 64] and sets a strong foundation for future investigations that will be impactful and
novel.

2.4.2. Future Work
The major limitation of this model is that it was assumed that the dECM coating
types differed in composition at the time of seeding and all types of protein within the
coating adhered to the silicone membrane. Since the true compositional differences
between the healthy- and IPF-derived dECM is still largely unknown, a potential way to
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address this would be to send the samples for mass spectrometry analysis. Although mass
spectrometry analysis has been done on dECM derived from lungs [44, 60], there is a lack
of information on IPF-derived dECM, and one group has recently shown that enzymatic
digestion might remove unique proteins of the matrix that might play a large role in disease
pathophysiology [103].
Therefore, dECM samples from the healthy and IPF patients should be sent for
mass spectrometry analysis both after being digested by enzymatic means (i.e., pepsin),
and only after being buffer extracted (i.e., mild laemmli sample buffer) to compare the
effects this step has on the protein hits found from this assay. Additionally, large mass
spectrometry protein databases do not exist for samples that have been pepsin digested, so
researchers that use dECM protein coatings that have been pepsin digested are relying on
the assumption that pepsin digested dECM content is similar to buffer extracted dECM
content and could be potentially using an inappropriate platform and dataset to analyze the
protein content for mass spectrometry. Therefore, it has not actually been confirmed this
enzymatic digestion step that improves the consistency and solubilization of the coatings
is not also having a detrimental effect on certain proteins. Once these steps are
accomplished, it would significantly help answer the questions of biology and would likely
provide valuable insight into the quantitative data that was presented.
Future work should also focus on transitioning this model to embedding different
types of cells within a stiffness modulated dECM 3D hydrogel. This would allow for the
cells to sense their environment, both the stiffness and composition, from all directions
instead of just underneath them. This would also lead to cell growth within a more
physiologically relevant environment closely replicating in vivo lung tissue. Additionally,
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cell behavior is drastically adjusted based on whether the culture system relies more on a
conventional 2D culture system or can achieve a more complex and representative 3D
culture modality. Once the 3D hydrogel system is validated, one could even start culturing
organoids within them to potentially address a major limitation within the field, the fact
many cultures are only able to support one cell type and do not consider how cells modulate
or affect each other, which is a big relationship that needs to be further investigated.
Another focus of future work should entail modifying the cell seeding density or
experimental timeframe. By day 7, HLF cells on all stiffness plates reached full confluence,
especially those on the plastic plates. Once cells reach confluence and have limited room
to partake in cell behaviors including proliferation and migration, it drastically alters their
responses. In this model, the PrestoBlue™ values directly show this effect, as there is
significantly lower normalized values on day 7. Additionally, the imaging on day 5
suggests the cell confluence has reached approximately 80%, and by day 7, it is apparent
that full confluence or near 100% has been reached by visual inspection. Two ways this
could be addressed in the future is to start the model with less than 20,000 HLF cells per
well at the time of seeding or to stop the experiment at day 5, while keeping the seeding
density the same. It would also be interesting if day 7 was eliminated to do RNA isolation
on days 3 and 5 to get a better picture of how the model is developing with time.
Implementing these proposed changes would likely help parse out the impact of the
stiffness and composition on the HLF cells without the confluence potentially confounding
these results.
Lastly, an additional proposed direction this work could be taken is to use the
same model, but with iAT2 cells, or another relevant distal lung epithelial cell type. IPF is
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an interstitial lung disease that impacts both fibroblast and epithelial cells within the
alveolar region. Thus, this could provide great information about the mechanisms that drive
the pathology and impact epithelial cell functions within these remodeled and diseased
areas.

Chapter 3: Cyclic Mechanical Stretch
3.1. Introduction
Ventilation plays a large role in lung homeostasis and physiology as human lungs
continually inflate and deflate, undergoing cyclic mechanical stretch and strain. When a
patient’s oxygenation level is severely at risk, or there are clinical indications for the need
of mechanical ventilation, positive pressure ventilation is typically used. The goal of
positive mechanical ventilation is both to support defective ventilation and to provide fresh
gas to the alveoli, so oxygen transfers into the blood and circulates to the tissue, while
waste is removed [75]. This form of ventilation is necessary in many instances to mitigate
respiratory failure; however, it can result in significant lung damage if used for extended
durations [85].
Natural breathing relies on negative intrathoracic pressure mechanisms and is
necessary for optimal function of type 2 alveolar epithelial cells, particularly with respect
to surfactant production [68, 70, 81, 87]. However, positive pressure ventilation increases
the pressure difference between the alveoli and interstitial space and can lead to pulmonary
barotrauma or volutrauma [76]. As a result, the increased trans-alveolar pressure can lead
to leakage of air into the external alveolar space leading to alveolar rupture [76, 77]. During
positive pressure mechanical ventilation, stresses and strains are concentrated onto alveolar
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walls, which makes them more prone to mechanical failure [78]. Mechanical stretch applies
strain to the tissue, and a variety of studies have shown how mechanical stretch impacts a
variety of events including cell death or injury [70, 80, 81], permeability [73, 82, 83],
migration [84], and surfactant production and secretions [68, 70, 79].
Two methods have been predominantly used to conduct stretch experiments, those
using commercialized stretch machines, such as the Flexcell® device [67 – 69], and those
using custom-made stretch machines [6, 70 – 72]. In addition to choosing stretch
equipment, one must consider if they want to stretch monolayers of cells, apply stretch
through ventilation of the whole organ, or stretch hydrogels with cells embedded within a
hydrogel matrix. The work presented here implements the third option of stretching
hydrogels, which blends traditional 2D and novel 3D cell culture methods to improve our
understanding of stretch activated cellular mechanisms. There are limited studies that have
focused on this area within the field due to the difficulty in characterizing the entire strain
field.
Therefore, it was necessary to consider how stress would be applied to the cells and
what strain field the cells were likely to reside within. The paper by Geest et al. (2004) is
still one of the few [69, 71] that quantifies the complete strain field that is measured within
a Flexcell® plate membrane. The authors found that there is an average area of constant
radial strain from the center of the membrane out to ~9.7 mm, and an average area of
constant circumferential strain out to ~11.3 mm [69]. From these findings, it was clear that
cells would experience different strains when located directly in the center of the membrane
in comparison to when they are on more peripheral regions of the Flexcell® membrane
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(Figure 20) [69]. As such, this work confines the cell culture area to the center of the
membranes and works under the guidance of findings from that paper [69].
The next consideration for these stretch experiments was which relevant
physiologic endpoint to target. Surfactant secretions have been shown to initially increase
in response to stretch, then level off, and return to their control levels over time [67].
Additionally, another group found that variable stretch increases surfactant secretion and
may help overcome this plateau effect previously mentioned [70]. In addition to time, other
variables have been investigated through stretch studies. For instance, stretch has led to
epithelial cell differentiation [6] and the composition of the cell matrix [71] as well as the
amount of stretch applied [70, 71], have both been investigated and shown to impact
surfactant secretions.
Overall, there are few recent publications focused on conducting cyclic mechanical
stretch studies in type 2 human alveolar epithelial cells to fully characterize the impact of
stretch factors on surfactant secretion. More importantly, there are no studies that look at
ECM composition and stiffness in combination with stretch or stretching iAT2s.
Additionally, many mechanotransduction pathways involved in stretch are poorly
understood, such as the YAP/TAZ proteins involved in the Hippo cell signaling pathway
that have also been implicated in regulating surfactant production [101]. Currently, it is
still difficult to parse out the role of individual mechanical contributors since there are a
variety of mechanical stimuli involved in lung mechanics, including stretch, shear stress,
and pressure, where lung pressure gradients move air through the airways due to pressure
difference between the atmosphere and the gases within the lungs. Additionally, there are
other variables at play, such as composition and stiffness which also impact breathing and
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can be incorporated into stretch experiments to create physiologically relevant models.
Therefore, this work focuses on the mechanical stimuli of stretch and this research aims to
add to the literature by presenting a methodology that is adaptable and useful for stretching
relevant lung cells within a 3D culture matrix of tunable composition and stiffness.

3.1.1. Background
3.1.1.1 Advantages and Disadvantages of Custom-Made and Commercialized
Machines that Led to Machine Choice for the Experiments
In our laboratory, there are two different types of stretching machines available,
one that was custom-built by Dr. Béla Suki, and another one that is a commercialized
machine that will be referred to as the Flexcell® or Flexcell® machine but is technically
the Flexcell® FX-5000™ Tension system (Flexcell® International Corporation) (Figure
17). Each machine has its strengths and limitations, but it was important to consider the
features of each to choose the best machine for this application. Therefore, many aspects
of each machine were considered before it was decided that the Flexcell® machine would
be used.
The first consideration that was assessed was whether the machines were working
appropriately and had the required software available for use, since both the Flexcell® and
Suki Stretch Machine have been in use for many years. After confirming both machines
functioned, the software versions of each were updated, and multiple runs were conducted
with each machine to ensure that all components were working as intended and interfacing
well with the computer software. Subsequently, the second area of consideration was
addressed which involved taking an inventory of available accessories for each machine to
determine the type of stretch one could apply with the equipment.
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Figure 17. Flexcell® FX-5000™ Tension system set up.

Biaxial strain is a better choice for modeling cyclic strains within pulmonary
alveoli since uniaxial strain does not completely mimic 3D deflection that is experienced
within the tissue [102]. Figure 18A and 18B depicts the difference between uniaxial and
biaxial stretch, respectively, and Figure 18C shows how the Flexcell® applies biaxial
stretch to the membranes and impacts cells. Therefore, biaxial stretching was chosen as the
modality for these studies, and it became clear that the Flexcell® would be able to run both
biaxial and uniaxial stretching regimens, while the Suki Stretch Machine would only be
able to run biaxial stretching regimens. The Flexcell® had removable posts that allowed
for multiple types of silicon membrane plates to be used with the system that enabled two
forms of stretch, while the Suki Machine did not. Furthermore, it was noted that the two
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systems operated differently. The Flexcell® is vacuum driven, while the Suki Stretch
Machine is piston driven, and relies on ball bearings to deliver the stress to the membrane.
Since both machines could provide the chosen biaxial stretch, it was not until a machine
delay was observed in the Suki Stretch Machine, that the Flexcell® was ultimately chosen.
The machine delay refers to the fact that the machine ran for longer than the programmed
value due to the software programming.

Figure 18. Depiction of different forms of stretch that can be applied by stretch
machines. (A) Shows uniaxial stretch, (B) shows biaxial stretch, and (C) depicts the
differences in the Flexcell® system when at rest versus when the machine applies biaxial
stretch to cells. Adapted from Flexcell® schematic of equibiaxial strain application to
cells cultured in a BioFlex® well and placed atop a cylindrical loading post that can be
found within their brochures.

To elaborate, both machines require a user to manually enter a duration for the
stretch protocol to run for. With the Suki Stretch Machine, if you entered a time, the
machine always ran longer than the theoretical duration, but this did not occur with the
Flexcell®. For the Suki Stretch Machine, the software was programmed to end the regimen
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once the number of cycles based off the frequency was reached. It was determined that the
software was reliant on a Windows computer to keep track of the cycle number and was
not using an internal timer. A determination was made that this resulted in a delay in timing,
one that was particularly noticeable, especially when longer regimens were run with this
machine.
For instance, when running a protocol with a sine wave, frequency of 1 Hz, 0%
static strain, and amplitude of 2% for 2800 minutes, the actual regimen was completed in
an average of 3459.8 minutes with a standard deviation of 0.2 minutes. These results meant
that the machine ran for ~124% of the original inputted duration. Although the run time
was much longer, the machine was very consistent and reproducible, which was supported
by the extremely small standard deviations observed (Tables 1 and 2). To further
investigate this phenomenon and characterize it appropriately, multiple protocols with
varying durations and frequencies were run. The results showed that the delay was linear
to the input for duration, and the frequency only had a small impact on the slope at these
conditions (Figure 19). To circumvent this, the user could decide to physically stop the
machine at the intended stopping point, or consistently wait for the protocol to finish and
note the delay in timing.
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Table 1. Suki Timing Delay of Machine at 1 Hz, 0% Static Strain, & 2% Amplitude.
Programmed
Time
(Minutes)

Average Run
Time
(Minutes)

Standard
Deviation of
Run Time

Delay in
Timing (%)

0.5

0.6

0

20

1

1.2

0

20

30

36.04

0.01

20.15

60

72.09

0.01

20.15

2800

3459.81

0.21

16.76

Table 2. Suki Timing Delay of Machine at 2 Hz, 0% Static Strain, & 2% Amplitude.
Programmed
Time
(Minutes)

Average Run
Time
(Minutes)

Standard
Deviation of
Run Time

Delay in
Timing (%)

0.5

0.6

0

20

1

1.2

0

20

30

36.06

0.01

20.20

60

72.09

0.02

20.16

2800

3460.94

0.18

16.72

Figure 19. Suki Stretch Machine timing delay tested at 2% amplitude and 0% static
strain with a sine wave for various durations and either a 1 Hz or 2 Hz frequency
which show a linear delay. (A) Protocol run at 1 Hz. (B) Protocol run at 2 Hz. The blue
lines represent the measured data, while the orange lines represent the theoretical data,
and the equations are provided on the graphs.
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While this observation was being addressed and further investigated, validation
of percent stretch began with the available Flexcell®. A more detailed explanation of these
steps is presented in section 3.1.1.2, but the main conclusion was that the machine was out
of calibration, which was identifiable by the minimum elongation value. A machine in
calibration should have a minimum value no greater than 0.5, and should ideally be much
closer to 0.3, unless it is being run at high frequencies. In theory, the minimum should be
0, but this is not achievable. The vacuum does not apply positive pressure to the system to
help the membrane return to its original state, so there is always some remnant air left
within the inlet and outlet tubes which provides one possible explanation as to why the
minimum will never in practice reach 0. Furthermore, there are multiple seals present
within the system, and if small leaks are present, this also increases the minimum value.
After initially seeing that the machine was not in calibration, the machine was sent back to
the company, and it was identified that one of the air flow valves was damaged, likely due
to moisture build up over time and insufficient drying regimens being run by previous
users. Thus, once the machine was returned and repaired, published methods were modified
slightly to conduct image validation with the Flexcell® [71, 81]. The negative issues that
were initially identified to choosing this system were addressed, and the machine was ready
for use before the issues with the Suki Stretch Machine could be addressed, so a decision
was made to move forward with the Flexcell® for the studies. However, this process helped
identify many major advantages and disadvantages of each system which can be seen in
Table 3.
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Table 3. Advantages and Disadvantages of the Two Discussed Stretch Machines.
Flexcell®

Suki Stretch Machine

Advantages

Disadvantages

Advantages

Disadvantages

The machine can deliver
both biaxial and uniaxial
stretch

Requires a lubricant to be
added to bottom surface of
the silicon membranes which
makes imaging difficult

Does not require a lubricant
to be added to bottom
surface of the silicon
membranes which makes
imaging difficult

There was a delay in timing
that has since been addressed
with a software patch, but
was not fixed during the time
of the study

The machine is a
commercial product and can
be sent back to the company
when repairs are needed

There are many components
to this system, and it takes a
significant amount of time to
set up

Less components which
make the machine easier to
use

The machine can only deliver
biaxial stretch

The research and
development department are
available to answer technical
questions

A drying regimen should be
run before experiments are
conducted and water traps
need to be monitored and
addressed as needed

Does not use a vacuum and
air system so it is easier to
maneuver and fit in small
places

Although Dr. Suki provided
technical support and was
able to send updated source
code, this collaboration may
not be available to others as
readily

The machine comes with a
well-documented user
manual

Stretch plates are run on the
baseplate, but non-stretch
plates must sit beside the
machine

Both stretch and non-stretch
plates can be run
simultaneously on the
machine as the posts are
removable

The machine calibration can
easily be checked frequently

The machine although
capable of running at faster
frequencies, drastically
decreases in performance
starting at 1 Hz

The machine is able to run
protocols up to 2 Hz

The software interface takes
a bit of time to get familiar
with it and feel comfortable
with using it

The machine has a simple
and straightforward user
interface
The machine is compatible
with commercial plates like
those by Flexcell®
International Corporation or
can use plates custom made
with a 3D printed template
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3.1.1.2 2D Image Validation of Silicone Membrane Percent Area Stretch
Since it is difficult to measure actual strain applied to the cells, most choose to
measure percent area increase of the silicone membranes as a form of quantitative
measurement for the change within the system. To do this, the Flexcell® FX-5000™
Tension system (Flexcell®, Flexcell® International Corporation, NC, USA) components
were set up appropriately and in accordance with the manufacturer’s instructions. Then,
untreated BioFlex® Culture plates (Flexcell® International Corporation) were obtained,
and geometrical markings were marked on the bottom surface of the membranes to serve
as reference points (Figure 20). Afterwards, the 25 mm BioFlex® Loading Stations™
(Flexcell® International Corporation) were coated with a thin layer of silicone lubricant
(Loctite, OH, USA, cat. # 51360) and white lithium grease (AGS, MI, USA, cat. # WL-1)
mixed in a 1:1 ratio with a paintbrush.

Figure 20. An untreated BioFlex® Culture plate with geometrical markings on the
membrane which was used for characterizations.

Next, the plates were added and the Flexcell® software was programmed for a
maximum percent biaxial elongation of either 2%, 3.5%, or 5%. Each time, a static protocol
was utilized which ran for 10 seconds with a frequency of 1 Hz. This allowed for pre57

stretch and post-stretch images to be acquired with an iPhone XS, and then the images were
uploaded into ImageJ (Version 1.53j, National Institutes of Health) to be analyzed. Also,
within ImageJ, a scale was set and universally applied to all images. Using the circle tool,
the area within the reference dots on the membrane were measured before and after stretch
to calculate an observed percent area increase of the silicone membrane within the confined
region using the equation below:
𝑃𝑒𝑟𝑐𝑒𝑛𝑡 𝐴𝑟𝑒𝑎 𝐼𝑛𝑐𝑟𝑒𝑎𝑠𝑒 =

(𝐴𝑟𝑒𝑎 𝑜𝑓 𝑆𝑡𝑟𝑒𝑡𝑐ℎ𝑒𝑑 𝑀𝑒𝑚𝑏𝑟𝑎𝑛𝑒 − 𝐴𝑟𝑒𝑎 𝑜𝑓 𝑈𝑛𝑠𝑡𝑟𝑒𝑡𝑐ℎ𝑒𝑑 𝑀𝑒𝑚𝑏𝑟𝑎𝑛𝑒)
∗ 100
𝐴𝑟𝑒𝑎 𝑜𝑓 𝑈𝑛𝑠𝑡𝑟𝑒𝑡𝑐ℎ𝑒𝑑 𝑀𝑒𝑚𝑏𝑟𝑎𝑛𝑒

This process was used to facilitate calculations for each well within a plate and
was repeated three separate times so results are presented as mean ± standard deviation.
The findings showed that if a user programmed a maximum percent biaxial elongation
value, it correlated with a larger percent area increase of the membrane. For instance, a
programmed 5% maximum percent biaxial elongation resulted in a larger measured percent
area increase, of ~9.1%. Furthermore, when comparing the measured percent surface area
increase of the membrane to the theoretical maximum percent biaxial elongation, the
percent errors were large, reaching as high as 128% (data not shown). However, a pattern
was observed, and it was identified that although the calculated percent surface area
increases were inaccurate, they were very precise. Thus, multiple amounts of stretch were
applied and used for image calibration to discern if an equation could be used to convert
theoretical maximum percent biaxial elongation into an actual observed percent surface
area increase.
Figure 21 depicts these findings and shows these variables are highly correlated
through a linear relationship. The equation allows a user to extrapolate and calculate
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various amounts of stretch that could be applied to the cells for stretch studies with cell
monolayers. For instance, if a user wanted to have the percent increase of the membrane
be 5%, one would program the protocol for 2.9% using the provided equation (Figure 21).
Finally, all stretch protocols were tested in this manner, and the percent error between the
theoretical and observed stretch had to be less than an averaged 10% to be considered for
experimental use.

Figure 21. A linear relationship is observed between 2 – 5% programmed stretch
and measured stretch using the 2D characterization method presented.

3.1.1.3 Development of Induced Pluripotent Derived Alveolar Type II Epithelial
Cells
Human induced pluripotent stem cells (iPSCs) were developed in 2007, but it was
not until 2017 that iPSCs were used to derive induced lung alveolar epithelial type II cells
(iAT2s) in vitro [86]. iPSCs are reprogrammed adult cells, with the regained potency of
embryonic stem cells. iPSCs can then undergo direct differentiation with growth factors
and/or ECM modulation to help direct the cell to a specific lineage. In the case of iAT2
cells, a defined directed differentiation media is used and composed of Wnt, FGF, and
corticosteroids [86, 87]. It is also important to note that iAT2s we utilized, obtained from
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a collaborator at Boston University, were engineered to contain an endogenous tdTomato
reporter on the type 2 alveolar epithelial cell specific surfactant protein C (SPC) locus. As
such, the cells will fluoresce in the visible red wavelength when SPC is being transcribed.
These iAT2s form organoids (i.e., spheroids or alveolospheres) in 3D culture, exhibit
mature AT2 phenotypes by virtue of SPC and other relevant gene and protein expression,
and are amenable to long term cultures (~1 year) [86, 87]. Of note most iAT2 cultures to
date have been done in Matrigel®, a widely used matrix derived from mouse sarcoma cells.
There is virtually no information currently available about growing iAT2s in human lungderived ECM or of effects of matrix stiffness on cell behaviors.

3.1.2. Preliminary Studies
Previous members of the Weiss Lab conducted preliminary cyclic mechanical
stretching experiments with a variety of cells. The most relevant data that was obtained
from this work came from using C10 cells, mouse type II alveolar epithelial cells. A
significant difference that is important to note is that uniaxial stretch was applied for this
work, and it was with 2D cell culture monolayers, whereas the data presented in this thesis
utilizes biaxial stretching and has cells embedded within 3D hydrogels. Nonetheless, both
studies used the same commercialized Flexcell® International Corporation machine.
Additionally, what the preliminary work showed is that the composition of coatings
manufactured by the company and purchased ready to go, the C10 cells were seeded on
had a direct impact on SPC, YAP, and ZO-1 expression after 24 hours of uniaxial stretch
was applied with 2% elongation at a frequency of 1 Hz.
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There was no statistical significance present amongst conditions for SPC and YAP
expression, but there certainly were strong trends. The average SPC expression in the
stretched samples was higher than the unstretched samples when on laminin and collagen
I coatings, and very similar expressions were observed in collagen IV coatings (Figure
22). Furthermore, Figure 22 shows the average YAP expression was lower in the stretched
samples across all coating types, and there was a large decrease in ZO-1 expression in the
stretched samples specifically on the laminin coatings (p = 0.002, represented by *).
Overall, this preliminary work suggests that SPC, YAP, and ZO-1 expression likely
depends on a variety of factors, such as cell-cell contacts, and composition likely has a
major role as well as cell-ECM interactions.

Figure 22. SPC, YAP, and ZO-1 expression of C10 cells when seeded on different
types of coatings.

3.1.3. Objectives
The goal of this work was to optimize a new methodology and validate that it could
be used to study the effects of cyclic mechanical stretch on cell functions cultured within a
3D matrix. For this study, Matrigel® was used as a proof of concept and iAT2s were used
as a model system. Furthermore, the hypothesis was that a combination of composition,
stiffness, and stretch can be utilized to study iAT2 biology and pathophysiology. As such,
the specific aims or objectives of this work were to do the following:
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1. To determine if stretching iAT2 cells embedded within Matrigel 3D cultures
influences viability and cell function.
2. To assess how the duration of stretch impacts SPC expression.
3. To initially investigate cell signaling pathways we postulate that are activated by
mechanotransduction in iAT2 cells. For this work, YAP/TAZ signaling was the
focus.

3.2. Approach and Methods
3.2.1. Characterization of 3D Hydrogel Percent Area Stretch with Image
Processing
The method discussed in section 3.1.1.2 serves as the foundation for transitioning
this process to accommodate a 3D hydrogel, which adds a third dimension to consider. The
height of the hydrogel meant that the top surface was no longer interfacing with the silicone
membrane, while the bottom surface was. Therefore, it was necessary to measure the
percent surface area increase at the hydrogel’s top surface to test if the strain had a different
effect with height and was non-uniform. There is currently a lack of literature on
characterizing hydrogel strain fields attached to silicone membranes. As such,
modifications to the original published image validation process [69, 71] were used as the
foundation and are discussed next in more depth.
Once again, the Flexcell® FX-5000™ Tension system (Flexcell®, Flexcell®
International Corporation, NC, USA) components were set up appropriately (Figure 17)
and in accordance with the manufacturer’s instructions. Then, untreated BioFlex® Culture
plates (Flexcell® International Corporation, cat. #BF-3001U) were obtained. However,
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instead of drawing geometrical markings on the bottom surface of the membranes to serve
as reference points, a Styrofoam template was created as seen in Figure 23A. The height
of the Styrofoam was 20 mm, the inner diameter circle diameter drawn on was 14.2 mm,
and the external diameter of the Styrofoam was 35 mm, which was approximately the same
as the untreated BioFlex® Culture plates (Flexcell® International Corporation, cat. #BF3001U) well diameter. This allowed for a tight fit when the Styrofoam was placed
underneath each well of the plate to guide the addition of Matrigel® in a consistent manner
(Figure 23B).

Figure 23. Styrofoam template used to add Matrigel to silicone membrane. The
confined region marked by the inner circle has a diameter of 14.2 mm. A) Depicts
Styrofoam mold created with identified constrained growth region and B) shows how the
mold was used to guide hydrogel addition to the membranes.

For each well within an untreated BioFlex® Culture plate (Flexcell® International
Corporation, cat. #BF-3001U), 100 μL of Matrigel® Growth Factor Reduced, Basement
Membrane Matrix, Phenol Red-free, LDEV-free (Corning®, AZ, USA, cat. #356231)
was pipetted onto the membrane by tracing the geometrical circle circumference of the
Styrofoam template and then was filled in radially. After each well was complete, the
plate was removed off the Styrofoam template, then transferred into a humidified
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incubator (5% CO2, 37°C, Thermo Fisher Scientific, cat. #3110) and was left for 30
minutes to solidify.
Afterwards, 2 mL of concentrated methylene blue was added to each well to stain
the hydrogel and add a contrast to improve visual boundaries. Next, the stain was
aspirated off. Then, the 25 mm BioFlex® Loading Stations™ were coated with a thin
layer of silicone lubricant (Loctite, cat. # 51360) and white lithium grease (AGS, cat. #
WL-1) mixed in a 1:1 ratio with a paintbrush. Next, the plate was loaded onto the
Flexcell® baseplate (Figure 17L) and the software was programmed for 3.8% theoretical
maximum percent biaxial elongation. Again, a static protocol was used and run for 10
seconds with a frequency of 1 Hz. Pre-stretch and post-stretch images were acquired with
an iPhone XS and the images were uploaded into ImageJ (Version 1.53j, National
Institutes of Health). Once again, a scale was set and globally applied to all images within
ImageJ. Using the circle tool, the perimeter of the top surface of the hydrogel was
measured from the before and after stretch photos to calculate a percent area increase, of
the hydrogel surface, instead of the membrane, using the equation:
𝑃𝑒𝑟𝑐𝑒𝑛𝑡 𝐴𝑟𝑒𝑎 𝐼𝑛𝑐𝑟𝑒𝑎𝑠𝑒 =

(𝐴𝑟𝑒𝑎 𝑜𝑓 𝑆𝑡𝑟𝑒𝑡𝑐ℎ𝑒𝑑 𝐻𝑦𝑑𝑟𝑜𝑔𝑒𝑙 − 𝐴𝑟𝑒𝑎 𝑜𝑓 𝑈𝑛𝑠𝑡𝑟𝑒𝑡𝑐ℎ𝑒𝑑 𝐻𝑦𝑑𝑟𝑜𝑔𝑒𝑙)
∗ 100
𝐴𝑟𝑒𝑎 𝑜𝑓 𝑈𝑛𝑠𝑡𝑟𝑒𝑡𝑐ℎ𝑒𝑑 𝐻𝑦𝑑𝑟𝑜𝑔𝑒𝑙

Hydrogels were added to each well of a plate and images were acquired each
time the protocol was run separately with each well. The ImageJ measurements were
repeated three times so percent area increases of the hydrogel are presented as mean ±
standard deviation.
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3.2.2. Harvesting iAT2 Cells and Plating Them for Experiments
iPSC-derived iAT2s were generously provided by Drs. Kotton and Ikonomou
(Center for Regenerative Medicine, Boston University). Published protocols describe their
full culture method [86, 87], but the key steps for this work included harvesting the iAT2
alveolospheres from Matrigel®, dissociating the alveolospheres to single cell,
resuspending the iAT2 cells in Matrigel® at a desired seeding density, and pipetting the
Matrigel® onto the membranes in a consistent manner with defined shape. In brief, this
was done by aspirating off the media from the alveolospheres in Matrigel® and replacing
the solution with 2 mg/mL dispase (Gibco, cat., MA, USA, #17105041). The dispase was
left on for 15 minutes with the plate in a humidified incubator (5% CO2, 37°C, Thermo
Fisher Scientific, MA, USA, cat. #3110). After the 15 minutes, the dispase was pipetted to
gently break up the Matrigel® within each well and the plate was returned to the humidified
incubator (5% CO2, 37°C) for another 15 minutes.
At this point, gentle pipetting occurred again to ensure all alveolospheres were
released from the Matrigel® which was confirmed with a brightfield microscope. The
solutions were then transferred into 10 mL of pre-warmed DMEM (Gibco, cat. #11054001)
and centrifuged (Allegra™ 6R Centrifuge, Beckman Coulter, IN, USA) at 200 rcf for 5
minutes. After aspirating off the supernatant, the iAT2 alveolospheres were resuspended
in 0.05% trypsin-EDTA (Gibco, cat. #25300120). The solution was transferred into a 6
well plate and incubated in a humidified incubator (5% CO2, 37°C) for a maximum of 15
minutes. The alveolospheres were checked after 10 minutes to assess the degree of
dissociation that had occurred and once the cells were at single cell level, the iAT2s were
washed with DMEM (Gibco, cat. #11054001) and supplemented with 10% FBS (HyClone,
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Cytiva, MA, USA). Following, the solutions were centrifuged (Allegra™ 6R Centrifuge,
Beckman Coulter) at 300 rcf for 5 minutes. Next, the iAT2s were resuspended in Growth
Factor Reduced, Basement Membrane Matrix, Phenol Red-free, LDEV-free Matrigel®
(Corning®, cat. #356231) that was thawed and kept on ice at a density of 400 cells/μL as
quantified by a hemocytometer (Thermo Fisher Scientific, cat. #0267151B). Additionally,
all conditions (non-stretched, non-stretched at 2 hours, non-stretched at 24 hours, stretched
at 2 hours, stretched at 24 hours) had three replicates as seen in Figure 24.

Figure 24. Experimental schematic showing culture conditions and time point
analyses. The necessary plates needed for the experiment is shown (A) as well as the
experimental assessments that occur over the course of the experiment (B).
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3.2.3. Adding Matrigel® to the BioFlex® Culture Plates
The Styrofoam template was added beneath each well of the untreated BioFlex®
Culture plates (Flexcell® International Corporation, cat. #BF-3001U) (Figure 23B).
Then, 100 μL of the iAT2s resuspended in Matrigel® was added to the silicone
membranes within the confined region of the area designated by the Styrofoam template.
The inner perimeter of the Styrofoam template was traced and radially filled in with the
Matrigel® to create consistently shaped and sized samples. Once all the iAT2s embedded
within Matrigel® had been added to the respective plates in accordance with the layout
seen in Figure 24, the plates were transferred into the humidified incubator (5% CO2,
37°C) for 30 minutes to allow the Matrigel® to solidify. Once the time had elapsed, the
plates were removed from the incubator and 2 mL of CK+DCI+Y media was added to
each well. The plates were then returned to the humidified incubator (5% CO2, 37°C) for
24 hours and then underwent another media change to just 3 mL of CK+DCI media just
before the experiment began.
The defined differentiation media, CK+DCI, was made with supplements of 3
µM CHIR99021 (Tocris, MN, USA, cat. #4423), 50 nM dexamethasone (Sigma, MO,
USA, cat. #D4902), 0.1 mM 8-bromoadenosine 3’,5’ cyclic monophosphate (Sigma, cat.
#B7880), 10 ng/mL recombinant human keratinocyte growth factor (R&D Systems, MN,
USA, cat. #251-KG-010), and 0.1 mM 3-isobutyl-1-methylxanthine (Sigma, cat. #I5879).
However, the full composition of the CK+DCI media can be found within the original
publications [86, 87]. Additionally, to create CK+DCI+Y media, the base media of
CK+DCI was supplemented with 10 µM Y-27632 (Tocris, cat. #1254) which helps prevent
dissociation-induced apoptosis.
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3.2.4. Stretching iAT2 Cells
For this study, iAT2s were embedded within thin hydrogels of Matrigel® that
were attached to silicone membranes. One subset of samples acted as a non-stretched
control and the other iAT2s were either stretched for 2 hours or 24 hours, to gain an initial
idea of how the stretch duration impacts AT2 functions, such as surfactant secretion. After
the necessary plates (Figure 24) were seeded with cells, the 25 mm BioFlex® Loading
Stations™ were coated with a paintbrush consisting of a thin layer of silicone lubricant
(Loctite, OH, USA, cat. # 51360) and white lithium grease (AGS, MI, USA, cat. # WL-1)
that was mixed in a 1:1 ratio (Figure 20). Next, all plates to be stretched were loaded onto
the Flexcell® baseplate (Figure 17L), and the software was programmed.
The protocol consisted of a sine wave, frequency of 1 Hz, programmed minimum
percent elongation of 0, programmed maximum percent elongation of 3.8, duty cycle
percent of 50, and a duration of 24 hours, completed with two identical 12-hour segments,
which resulted in a total of 86,400 cycles. Once all the plates were loaded, 15 lbs of weight
was added to the plastic sheet that covers all plates on the baseplate to ensure an adequate
seal was achieved (Figure 17I). The inlet and outlet tubing were connected (Figure 17H),
the D8B leybold vacuum (Figure 17G) (Oerlikon, IL, USA) was turned on, the pressure
reserve (Figure 17F) was opened, and the appropriate protocol (Figure 17C) was loaded
and started. Finally, visual inspection was done with the waveform readout to confirm that
the protocol was running as intended for the course of the duration.
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3.2.5. Analysis of Epithelial Cell Morphology
To monitor cell morphology, both brightfield and fluorescent imaging was done
with 4X, 10X, and 20X objectives on an Olympus IX70 Inverted Light Microscope (UVM
Microscopy Imaging Center). Representative images were acquired before the experiment
began, at the 2-hour time point, and after the 24-hour time point for all sample types. Then,
images were processed in ImageJ (Version 1.53j, National Institutes of Health) and it was
anticipated that iAT2 cells would be spherical, single cell, fluorescent, and evenly
distributed throughout the Matrigel®. Additionally, notes of unique cell morphology and
debris or cell death were noted.

3.2.6. Analysis of Epithelial Cell Phenotype
3.2.6.1 RNA Isolation
At hours 0, 2, and 24, iAT2 cells were harvested for RNA isolation by aspirating
off the media from the wells, using a spatula to dislodge the hydrogel from the membrane,
and then transfers the hydrogels to individual wells within a 12 well plate (Fisher Scientific,
NH, USA, cat. #FB012928). Next, 1 mL of 2 mg/mL dispase (Gibco, cat. #17105041) was
added to each well and the plate was placed in a humidified incubator (5% CO2, 37°C) for
15 minutes. Afterwards, the Matrigel® within each well was gently broken up by the
dispase and then the plate was incubated (5% CO2, 37°C) for another 15 minutes. Again,
gentle pipetting occurred to ensure all iAT2s were released from the Matrigel®, and then,
the solutions were transferred to separate Eppendorf tubes. These tubes were centrifuged
(Eppendorf Centrifuge 5424) at 300 rcf for 5 minutes at 4°C. Following, the supernatant
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was manually aspirated off the cell pellet and the cell pellets were resuspended in 350 μL
of RLT buffer (Qiagen) and frozen at -80°C.
When all samples were collected, RNA was extracted using the RNeasy Plus
Micro Kit (Qiagen, MD, USA, cat. #74034) according to the manufacturer’s protocol.
Briefly, the RNA isolated in RLT buffer was thawed on ice and separately transferred into
the gDNA eliminator spin columns provided. The columns were centrifuged (Eppendorf
Centrifuge 5424) at 8000 rcf for 30 seconds, and then the gDNA eliminator spin column
was discarded. An equal volume of 70% ethanol was added to the flow-through, mixed
well, and then each solution was transferred into a RNeasy MiniElute spin column with a
2 mL collection tube beneath. After subsequent centrifugation at 8000 rcf for 30 seconds,
the flow through was discarded and 700 μL of RW1 buffer was added to the columns. The
next centrifugation step was done once more at 8000 rcf for 30 seconds. This process was
repeated with 500 μL of RPE buffer and 500 μL of 80% ethanol. Then, centrifugation was
2 minutes long to ensure that the columns were free of remaining RPE buffer. An optional
step was then completed, where the spin columns were placed into a new 2 mL collection
tube and centrifuged at maximum speed for 5 minutes as this step helped dry the membrane.
Then, the spin columns were individually transferred to a 1.5 mL collection tubes that were
provided and 14 μL of RNAse-free water was directly added to the spin columns. Again,
the tube was centrifuged (Eppendorf Centrifuge 5424) for 1 minute at 8000 rcf. This
resulted in an eluate being collected within the 1.5 mL collection tube and is referred to as
the final isolated RNA sample.
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Subsequently, the RNA samples were kept on ice and the RNA concentration was
quantified using the Nanodrop™ (Thermo Fisher Scientific), according to standard
protocol.

3.2.6.2 cDNA Synthesis by Reverse Transcription
RNA samples (~25 ng) were reverse transcribed into cDNA using the iScript™
cDNA Synthesis Kit (Bio-Rad, CA, USA, cat. #1708891), according to the manufacturer’s
protocol. Briefly, several kit reagents (Appendix Table 6) were mixed and ran on a
C1000™ Thermal Cycler (Bio-Rad) using the protocol outlined in Appendix Table 2.
Afterwards, the cDNA was diluted with RNA free water 1:2, bringing the total volume to
40 ul, and the samples were stored at -20°C.

3.2.6.3 Quantitative PCR (qPCR)
qPCR gene expression assays were done using the iTaq Universal SYBR® Green
Supermix (Bio-Rad, cat. #1725125) kit and MicroAmp® Optical 384-Well Reaction plates
(Applied Biosystems, MA, USA, cat. #4309849). A solution of 0.625 ng/μL cDNA was
used with the master mix (Appendix Table 7), primers (Appendix Table 8), and the
reaction conditions (Appendix Table 4). Both positive and no template controls were
added to each plate and were tested for each gene, where the positive control was cDNA
from human lungs. All primers were purchased directly from Integrated DNA
Technologies (IDT, IA, USA) and the sequences for these genes can be found within
Appendix Table 8.
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Only the data that had clear melt curves, as generated by the qPCR software
analysis program, were used. For the analysis, all CT-values of the pipetted duplicates were
averaged. Then, the relative transcript abundance of a gene was calculated using the
standard ΔΔ CT method. For example, the average Δ CT-value of iAT2s at 0 hours was
subtracted from the Δ CT-value of iAT2s that were stretched for 2 hours. In short, the
stretched and non-stretched samples at both 2 hours and 24 hours were normalized to the
time 0 samples.

3.2.7. Data and Statistical Analyses
All qPCR data was assembled in Excel version 16.48 and statistical analyses and
graphs were generated with GraphPad Prism 8.2.1. This experiment was done once,
resulting in three total replicates for each end point condition. Due to the limitation of
repeated replicates and inability to meet the parametric assumptions (normality and equal
variance), non-parametric methods were employed. As such, all gene expression fold
change values are shown as median ± IQR within graphs.

3.3. Results and Discussion
3.3.1. Results
3.3.1.1 Image Processing Demonstrates that Stretched 3D Hydrogels Percent Area
Increase is Larger than the Programmed Value
The focus of this experiment was to take both brightfield and fluorescent images
and collect RNA from iAT2 samples that either underwent stretch for 2 or 24 hours, so
they could be compared to the non-stretched controls at these time points. However,
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before the actual experiment began, the first step was to apply 100 μL of Matrigel® to
the wells of an untreated BioFlex® Culture plate using the method described in full in
section 3.2.1. The results of the pre- and post-stretched images for wells 1 – 3, which
were the only wells used during the experiment, are presented in Table 4 to show the
average measured percent area change of the Matrigel® top surface. Again, the protocol
consisted of a programmed 3.8% maximum elongation, and the overall average measured
percent area change of the Matrigel® top surface for wells 1-3 was 8.96%. The standard
deviation of the repeated image characterization can be seen in Table 4 as well, and it is
also helpful to see the range of values that were measured for these wells.
Table 4. Results of Image Processing of Matrigel® with Wells Used During the
Experiment.
Well Number
1
2
3
Combined Wells 1 – 3

Average Measured Area Change
(%)
7.65
9.44
9.81
8.96

Average Standard
Deviation
0.58
0.35
0.65
1.15

3.3.1.2 Stretch Impacts Epithelial Cell Morphology
Once the initial hydrogel stretching characterization was done, the data was
collected from the full experiment. Imaging was crucial to monitor morphology and
tdTomato expression, which provided insight into SPC expression. Representative
images from each time point and condition can be seen in Figures 25 – 29. More
specifically, representative images from iAT2 at time 0 hrs are seen in Figure 25,
representative images from iAT2 at time 2 hrs that were exposed to stretch can be seen
in Figure 26, and representative images from iAT2 at time 2 hrs that were not stretched
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can be seen in Figure 27. All these figures also included areas of interest that were
enlarged to make it easier to interpret and see the distinct morphologies and fluorescent
marker present.

Figure 25. Representative images from iAT2 at time 0 hr. Regions of interest were
identified by boxes A, B, and C and enlarged on the right of the full image. Scale bars are
indicated on the images.

Figure 26. Representative images from stretched iAT2 at time 2 hrs. Regions of
interest were identified by boxes A, B, and C and enlarged on the right of the full image.
Scale bars are indicated on the images.
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Figure 27. Representative images from non-stretched iAT2 at time 2 hrs. Regions of
interest were identified by boxes A, B, and C and enlarged on the right of the full image.
Scale bars are indicated on the images.

Similarly, this was also done with the samples at hour 24. Figure 28 shows a
representative image of the iAT2s in Matrigel® after being stretched while Figure 29
provides the control representative image of the iAT2s in Matrigel® that were not
stretched. During the imaging sessions, cells with morphology like those visible in Figure
26 region of interest box C and Figure 28 region of interest box B were found throughout
stretched samples. Additionally, by visual inspection, it also appeared that were a larger
number of cell bodies that looked like these elongated and hollow cells in the samples that
were stretched for 24 hours, while very few were identified in the 2-hour stretched sample
plate.
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Figure 28. Representative images from stretched iAT2 at time 24 hrs. Regions of
interest were identified by boxes A, B, and C and enlarged on the right of the full image.
Scale bars are indicated on the images.

Figure 29. Representative images from non-stretched iAT2 at time 24 hrs. Regions
of interest were identified by boxes A, B, and C and enlarged on the right of the full
image. Scale bars are indicated on the images.

3.3.1.3 Gene Expression
Lastly, gene expression was assessed both at the 2 and 24-hour marks. Several
genes were monitored, such as type II epithelial cell markers (SPC, LAMP3, and ABCA3),
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a type I epithelial cell marker (AGER), Hippo signaling markers (YAP and TAZ), and an
apoptosis marker (Casp3), which can be seen in Figure 30. Most notably, it appears the
medians of both SPC and Casp3 expression is very similar in all conditions (Figure 30).
Additionally, LAMP3 expression at both the 2 hour and 24-hour time points was
upregulated in the non-stretched samples (Figure 30). Furthermore, YAP in the stretched
samples was upregulated at the 2-hour time point and then very similar to the non-stretched
sample by hour 24 (Figure 30).
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Figure 30. Relevant target gene expression for epithelial cell biology at 2 hours or 24
hours for stretched and non-stretched samples. (N=3, median ± IQR). The effects of
stretch at 2 hours and 24 hours on gene expression for markers of type II epithelial cells
(A), type I epithelial cells (B), the Hippo signaling pathway (C), and apoptosis (D).

3.3.2. Discussion
There are a variety of ways to apply mechanical strain to cells, but this model
focused on applying cyclic biaxial strain with a vacuum driven stretch machine to lung
type II epithelial cells. The experimental design also focused on validating a new
methodology that was optimized and used to study the effects of cyclic mechanical stretch
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on cell functions cultured within a 3D matrix. As such, the bulk of time was spent on
validating the equipment and methodologies to be utilized. The major limitation of this
study was that it was only composed of three actual experimental replicates, which limits
the interpretation of the results and statistical analysis. Another significant challenge to this
study was that iAT2 cells are challenging to culture and very sensitive to environmental
stress and changes. Additionally, these cells take multiple weeks to proliferate and expand
out, which limited how readily available they were for use. The current SARS-coV-2
pandemic also greatly impacted material availability for products that were needed for cell
culturing, such as Matrigel®, and a variety of the cell culture media components. Despite
these limitations, this work serves as a platform and is the first of its kind to stretch iAT2s,
which are highly sought after and novel due to their remarkable physiological relevance
and unique characteristics. This proof-of-concept work identified several areas of strengths
and weaknesses of this model, which will be further explored in subsequent studies.
For example, the method employed to measure percent area increase through
image processing is useful and more commonly being used, but the results presented in
Table 4, were only repeated once. When this characterization of the hydrogel surface area
increase is repeated at least two more times, the result will be three experimental replicates
with an additional three technical replicates each time, bringing the total number of
replicates to 9. This could potentially identify variability within in the silicone membranes
of the BioFlex® Culture plates and help produce a more representative mean value for each
well across multiple plates. Due to volume availability, using 600 μL of Matrigel® each
time, for a total of 1800 μL of Matrigel®, was just not possible before starting this study.
As such, it is difficult to discern if well 1 which had an averaged measured area change of
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7.65%, would be higher and closer to the values of wells 2 and 3, which were 9.44% and
9.81% respectively (Table 4). Interwell variability may also have affected the gene
expression values that are seen within Figure 30 and could provide a potential explanation
as to why the IQR ranges for stretched samples are considerably larger than many of the
non-stretch samples.
Additionally, throughout this process efforts were made to minimize the height of
the Matrigel® and produce consistently shaped hydrogel samples. This study design
worked under the assumption that the strain measured at the top of the Matrigel® would
be like the strain that would be measured at the bottom of the Matrigel®, since height was
minimized. However, this image processing method only characterized the most superficial
surface of the samples, so a complete understanding of the strain occurring throughout the
entire sample is a limitation of this study. Future work should work to measure strain or
percent area increase at a variety of heights since the iAT2 cells are resuspended throughout
the entire Matrigel® sample and fall at different heights, which might impact the results
considerably.
In addition to the image processing characterization that measured changes within
the Matrigel® sample, two other forms of assessment were utilized throughout this study.
Imaging was crucial as the iAT2s are endogenously labeled with a tdTomato reporter that
corresponds to SPC expression. Furthermore, cell morphology was able to be monitored
over the entire course of this study and provided significant insight into the health, shape,
and behaviors that were occurring throughout the samples. Figure 25 provided
representative images showing the iAT2s at a single cell level within Matrigel® at hour 0.
Significant amount of red fluorescence was observed throughout the samples and supported
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high viability of the cells at this point by assessing their morphology, since they were nicely
rounded and uniform maintaining their cuboidal type II epithelial shape, and little to no
cell debris was seen. Then, once the experimental time began and a portion of the samples
underwent stretching, imaging was repeated at hour 2 (Figures 26 and 27). Figure 26
presents representative imaging of iAT2s that experienced stretch while Figure 27 presents
representative imaging of iAT2s that were not stretched. In both Figures 26 and 27, again
high fluorescence was observed, and the cells remained alive and nicely rounded and
uniform. However, within the stretched samples, very few occurrences of cells that
appeared more elongated, with hollow centers, and retained fluorescence were seen
(Figure 26, region of interest C).
Then, Figures 28 and 29 show representative images at the hour 24-mark, where
Figure 28 corresponds to stretched iAT2s, and Figure 29 corresponds to non-stretched
iAT2s. Again, in both Figures 28 and 29, high fluorescence was observed, and most cells
remained alive, nicely rounded, and uniform. Additionally, within the stretched samples,
even more occurrences of cells that appeared elongated and with hollow centers, were seen
(Figure 28, region of interest B). Both images of iAT2s stretched and non-stretched were
taken with higher objectives at the 24-hour mark, and Figures 28 and 29 show
representative instances of what cell morphologies were mostly common within their
respective samples.
Figure 30 provides the qPCR data and fold changes for all samples. Multiple
types of genes were monitored, including AT2 markers (Figure 30A), AT1 markers
(Figure 30B), Hippo signaling (Figure 30C), and apoptosis (Figure 30D). Focusing on
the AT2 marker of SPC, the median values between the stretched and non-stretched
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samples was unremarkable, as the medians were approximately the same. However, there
was a large IQR for the 2 hour stretched samples. Then, looking at LAMP3, both nonstretched samples (non-stretched at 2 hours and non-stretched at 24 hours) had larger
medians than the corresponding stretch samples. Additionally, there was a noticeable
increase in the median of the non-stretched 24-hour sample gene expression compared to
the non-stretched 2-hour sample gene expression, while the medians for the stretched
samples remained constant. Lastly, the third AT2 marker of ABCA3 also showed similar
expression levels for the stretched and non-stretched samples but did see an increase in
expression between the 2 hour and 24-hour samples, where the stretched and non-stretched
iAT2s had fold changes of ~3 at 24 hours while they were ~1.5 at 2 hours.
Based on the literature and functionality of AT2 cells, it was anticipated that the
stretched samples might see increased SPC gene expression since mechanical stimuli has
been shown to impact SPC production in type II epithelial cells [68, 70, 79]. Additionally,
excessive stretch has also been shown to cause cell death and injury [70, 80, 81], but the
medians of the stretched and non-stretched iAT2 samples were similar (Figure 30D) and
suggests the protocol implemented did not apply too much mechanical strain that caused
negative effects on the cells. Furthermore, it was anticipated that the Hippo signaling
pathway would be upregulated in the stretched samples because mechanical stretch affects
cell permeability [73, 82, 83] and can impact YAP and TAZ expression and cytoplasm
retention [10, 33, 34, 88, 89]. Figure 30C shows a slight upregulation in YAP expression
in the stretched iAT2s at 2 hours but has a large IQR that should be noted as well.
Additionally, by 24 hours, this upregulation is no longer present as the stretched and non-
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stretched medians are extremely similar. Furthermore, there are no unremarkable
differences between stretched and non-stretched medians for TAZ expression.
Lastly, since no one has been able to show iAT2 differentiation to iAT1s through
mechanical manipulation, it was anticipated that the AT1 marker, AGER, would not be
upregulated. Despite this, Figure 30B shows a slight increase in the median of the stretched
iAT2 samples at hour 2, but decreased expression compared to the non-stretched samples
at hour 24. Therefore, taking into consideration the wide heterogeneity observed within the
AT2 and AT1 markers, major conclusions should not be made that determines stretch
clearly influences the gene expression of iAT2s based on these limited results.
However, it is still important to note that Figures 26 and 28, show distinct
morphological changes that were observed throughout all stretched samples that were not
observed in the non-stretch control samples. Additionally, more of these cells with distinct
morphology were easily identifiable in the samples that experienced longer periods of
stretch. However, a conclusion such as suggesting that differentiation may be occurring is
highly speculative at this point and needs to be further investigated through experimental
replicates and other experimental assessments. The gene expression data obtained from
qPCR showed no distinct trends overall when comparing stretched versus unstretched
iAT2s, so it makes it difficult to support a statement such as this one currently, although
interesting observations can still be noted. To further investigate these morphological
changes that were observed significantly in the stretched samples, two methods should be
employed and will be discussed in greater depth in the following future work study of this
chapter.
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3.4. Conclusion and Future Work
3.4.1. Conclusion
This study provides valuable information that will help researchers and clinicians
better understand how mechanical strain affects type II lung epithelial cells, especially
with a focus on how cyclic mechanical stretch may impact surfactant secretions, a crucial
component of the alveoli and normal lung physiology. The commercialized Flexcell®
machine was programmed to deliver a maximum percent elongation of 3.8%, which was
measured and translated into an average percent area increase of 8.96% for 100 μL
Matrigel® samples with 14.2 mm diameters at the superficial surface. Both imaging and
qPCR assessments were done to monitor cellular morphology and gene expression,
respectively. The imaging showed unique morphological changes in some iAT2 cells that
underwent stretch, while this was not observed in the non-stretched samples. However,
the qPCR data was variable and did not provide clear conclusions that provided insight
into this event, so future work is necessary for this study to improve its reproducibility
and significance. Meanwhile, the methodology presented is valuable to those attempting
to stretch lung cells and reproduce physiologically relevant model systems incorporating
mechanical stimuli, as there have been limited attempts to date, and novel cells were
utilized.

3.4.2. Future Work
To increase the strength of this study design and current results, replicating the
experiment two more times to produce a greater number of replicates that would allow
for statistical analyses to be done. Additionally, in the future, it would be potentially
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beneficial to purchase the FX-6000™ Tension system (Flexcell® International
Corporation) if similar stretch studies are going to be pursued. The newer system is
improved and addresses many limitations of the older model and would be able to apply
equal cyclic deformation to cells grown in 3D through their validated machine, and the
machine could be run at higher frequencies since it uses positive pressure, which would
allow for users to simulate a wider variety of in vivo frequencies and strains. This study
implemented a frequency of 1 Hz while stretching the iAT2 cells, not because it fell into
the physiologically relevant normal breathing frequency, but more to highlight the
maximum error that would be observed from the machine. The machine works
considerably worse and is not able to maintain consistent stretching above 1 Hz, so an
initial protocol using 1 Hz was used to try and measure the most variability in results that
would be observed so the method could be optimized accounting for the machine having
the most variability so when future protocols are tested, the results will likely only
improve significantly.
Another consideration that should be investigated in future studies is whether the
silicone membranes experience plastic deformations over long durations of stretch. This
would be important to characterize especially if this impacts how the stress is applied to
the cells and changes the strain field acting on the cells. If this were to occur, the
mechanical forces acting on the cells will likely not be consistent and could have large
impacts on cell behaviors and gene expression. This is one reason why the maximum
time of stretching the iAT2 cells was 24 hours, but future studies should stretch iAT2
cells for longer durations. Furthermore, the image processing characterization to measure
percent area increase of the hydrogels was done before the experiment began and did not
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entail submerging the Matrigel® in a liquid solution as was done when the iAT2s were
covered by cell media. Hydrogels are prone to significant swelling and degradation, so
this could be implemented into the current methodology used. Additionally, the image
processing was done from images taken before and after a short duration of static stretch
was applied. However, it would also be interesting to keep stretching these same
hydrogels for the full 24 hours and then retake the images to see if the hydrogels surface
area increased due to swelling over the duration and impacted percent area increase.
Lastly, since the gene expression results were variable and difficult to interpret,
employing either flow cytometry to sort cells based on protein markers or doing
immunofluorescence staining for the same markers could be extremely helpful in providing
additional biological information. If multiple modalities of analysis were employed, there
would likely be a better way at analyzing what is occurring within the Matrigel® samples,
especially in the cells that appear elongated, hollow, and almost AT1 like.
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Chapter 4: Concluding Remarks
4.1. Stiffness and Composition
Models incorporating modulations to both stiffness and composition hold
significant promise in recreating the most physiologically relevant in vivo lung systems
that could provide impactful results that help advance the field considerably. It is widely
acknowledged that each of these factors plays a large role in cellular behaviors, and
drastically change when chronic lung diseases occur. This study in particular highlights
how a model incorporating both variables of stiffness and composition becomes complex
and challenging to execute and interpret the results in a meaningful way. However, this
study utilized dECM lyophilate derived from healthy and IPF patients, which was the
first attempt at creating protein coating solutions on CytoSoft® plates and resulted in a
straightforward and useful system that will help parse out individual contributions in a
consistent manner. Additionally, this work provides a platform for future studies and will
provide impactful points of consideration for researchers attempting to conduct similar
work, especially with dECM material, something that is recently becoming extremely
popular.

4.2. Cyclic Mechanical Stretch
Although mechanical stretch is a fundamental event that occurs with breathing
and lung tissue, it is commonly overlooked and not included into models. There are very
few commercialized products that exist at do not present considerable cost burden on
researchers, so more researchers are turning to developing their own custom-made
machines. However, this poses an additional obstacle as each machine will likely be
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applying mechanical strain in distinct ways and potentially means each research group
will validate their machine and characterize the stretch in independent ways that align
best with their system. Therefore, a greater emphasis on conducting research studies with
these commercialized machines will improve the understanding of stretch on lung cells
and bright awareness to many of the challenges or considerations researchers should
employ before starting similar work. Additionally, this study with iAT2s is one of few
that attempts to stretch human lung epithelial cells within a 3D matrix, which increases
the complexity greatly. The current results need to be reproduced before major
conclusions are drawn, but this work holds great potential to provide insightful on
activation of cellular pathways and changes in gene expression. Lastly, the
morphological changes that were observed with the iAT2s in the stretched samples is an
interesting event to note as it may suggest differentiation could be occurring and could
potentially lead to subsequent full studies to conduct in the future.

4.3. Current and Future Work
There is a growing emphasis on developing new lung model systems that
incorporate multiple physiologically relevant variables and utilize material that closely
mimics in vivo tissue. A major area that is being explored for dECM material usage is
for 3D bioprinting. Reconstructing functional and biocompatible individual tissue
components, such as vasculature or airways, would be a tremendous step towards
producing whole organ scaffolds that can be used for clinical applications. For instance,
freeform reversible embedding of suspended hydrogels (FRESH) bioprinting as had great
success in producing structures that mimic features of organs. Recently, a heart was
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printed to scale of an adult from a patient-derived magnetic resonance imaging data sets
[97]. This opens the door to similar work being pursued in the field of pulmonary
medicine and could have large positive clinical benefits if structures are able to be
tailored to patients, but also contains appropriate functionality.
Meanwhile, this work accomplishes this aim in multiple ways, but also highlights
certain limitations that still exist and are common such as the fact that only one cell type
is used within each model and the work presented in Chapter 2 relies on protein coatings
instead of using 3D dECM matrices. There is still a large need in fully characterizing the
composition of native lung tissue, decellularized lung tissue, decellularized lung tissue
that has been enzymatically digested, and post-processed. Furthermore, although these
two independent methods from Chapters 2 and 3 provide improvements to previously
established efforts, future studies should work towards combining the two together. For
instance, stretch studies should resuspend relevant lung cells within dECM hydrogels.
Additionally, all this work should be reproduced to increase the total number of replicates
since there was significant variation present in the qPCR results.
Future studies are already underway by laboratory members that address the
suggestions and concerns that are presented throughout this thesis. This work is also
being prepared to be submitted as two separate manuscripts, and abstracts have been
submitted and accepted to conferences utilizing this content. Additionally, this work has
provided the opportunity to present multiple times and numerous skills have been learned
over the course of these studies. The experimental designs have been solidified and
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validated so future studies should occur quickly and holds the potential to continue to
improve the field of lung mechanobiology greatly.

4.4. Conclusion
Overall, the work presented in this thesis provides results from two independent
studies that each relied on new developed methodologies that each incorporated relevant
and critical mechanobiology variables relevant to lung physiology. Both models
incorporate components that improve physiological relevance and can answer biological
and mechanistic questions. This work bridges the gap between conventional 2D cell
culture models and novel 3D cell culturing techniques that will be exclusively pursued
in future studies. Numerous skills were developed through the course of this thesis
duration which will be utilized to improve engineered cell culture platforms that work to
mimic complete lung dynamics, composition, and the structure-function relationship that
are crucial to present in pivotal models.
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Appendix

Appendix Figure 1. Major detergent based decellularization steps for human lungs.
Native tissue to the most left and decellularized post-DNAse lung tissue to the furthest
right [Courtesy of Previous Weiss Lab Members].
Appendix Table 1. cDNA Synthesis by Reverse Transcription for Fibroblast Cells.
Reagent

Final Concentration
in 20 μL

Volume

5X iScript Reaction
Mix

4 μL

iScript Reverse
Transcriptase

1 μL

RNA Template

300 ng

Variable μL

Nuclease-Free Water

15 μL – Variable μL

Total

20 μL

Appendix Table 2. Reaction Conditions for cDNA Synthesis.
Repetitions

Cycle Step

Temperature

Time

1x

Priming

25 °C

5 min

1x

Reverse Transcription

46 °C

20 min

1x

RT inactivation

95 °C

1 min

1x

Cooling

4 °C

Hold on

100

Appendix Table 3. Master Mix for qPCR with Fibroblast Cells.
Reagent

Stock Concentration Final Concentration Volume

Forward Primer

10 μM

1 μM

1 μL

Reverse Primer

10 μM

1 μM

1 μL

cDNA

15 ng/μL

5 ng/μL

1 μL

Nuclease-Free Water
iTaq™ Universal SYBR®
Green Supermix

2 μL
2X

1X

5 μL

Total

10 μL
Appendix Table 4. Reaction Conditions for qPCR.

Repetitions

Cycle Step

Temperature

Time

1x

Initial Denaturing

95 °C

2 min

Denaturing

95 °C

30 s

Annealing

58 °C

20 s

Elongation

72 °C with continuous acquisition

30 s

95 °C

10 s

65 – 95 °C

Increment 0.5
°C every 0.05 s

40x
1x
1x

Melting curve

101

Appendix Table 5. Human Quantitative PCR Primers for Fibroblast Cells.
Gene
ACTA2
Casp3
Col1A1
Ki67
TAZ
TGF-β1
TIMP1
YAP
18S

Sequence 5’ – 3’

Melt Temperature

fw
rv
fw
rv
fw
rv
fw
rv
fw
rv
fw
rv
fw
rv

CTA TGC CTC TGG ACG CAC AAC T
CAG ATC CAG ACG CAT GAT GGC A
GCG TCG CCT TGA AAT CCC AG
GCA CAC CCA CCG AAA ACC AG
TTC TGT ACG CAG GTG ATT GG
CAT GTT CAG CTT TGT GGA CC
GGT TCG ACA AGT GGC CTT GC
CTC AGG GGA AAG TGG GGA CC
GGA CTC ACC CGA GCG ACC C
GGC CGG ATT CAT CTT CTG GGC G
CGA GCC TGA GGC CGA CTA C
AGA TTT CGT TGT GGG TTT CCA
CAT CCT GTT GCT GTG GCT CAT
GTC ATC TTG ATC TCA TAA CGC TGG

66.1 °C
66.5 °C
65.5 °C
65.7 °C
62.1 °C
61.4 °C
65.7 °C
65.8 °C
68 °C
68.8 °C
65.7 °C
62.5 °C
67.2 °C
63 °C

fw
rv
fw
rv

GCG CTC TTC AAC GCC GTC AT
GTA CTG GCC TGT CGG GAG TGG
GGC CCT GTA ATT GGA ATG AGT C
CCA AGA TCC AAC TAC GAG CTT

67.3 °C
67.7 °C
62.9 °C
61.9 °C

Appendix Table 6. cDNA Synthesis by Reverse Transcription with Epithelial Cells.
Reagent

Final Concentration
in 20 μL

Volume

5X iScript Reaction
Mix

4 μL

iScript Reverse
Transcriptase

1 μL

RNA Template

25 ng

Variable

Nuclease-Free Water

15 μL – Variable μL

Total

20 μL
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Appendix Table 7. Master Mix for qPCR with Epithelial Cells.
Reagent

Stock Concentration Final Concentration Volume

Forward Primer

10 μM

1 μM

1 μL

Reverse Primer

10 μM

1 μM

1 μL

cDNA

1.25 ng/μL

0.625 ng/μL

1 μL

Nuclease-Free Water
iTaq™ Universal SYBR®
Green Supermix

2 μL
2X

1X

5 μL

Total

10 μL

Appendix Table 8. Human Quantitative PCR Primers for Epithelial Cells.
Gene
ABCA3
AGER
Casp3
LAMP3
SPC
TAZ
YAP
18S

fw
rv
fw
rv
fw
rv
fw
rv
fw
rv
fw
rv
fw
rv
fw
rv

Sequence 5’ – 3’

Melt Temperature

TCT CAC AGT GAC GCT GCC AA
AGG AGC CTG TTT GGG TCC AC
GAA GGA TGG TGT GCC CTT GC
CAG CCC TGA TCC CAC AG
GCG TCG CCT TGA AAT CCC AG
GCA CAC CCA CCG AAA ACC AG
CGG GCA TTC CTT CAA GTG CG
AGG CAG AGA CCA ACC ACG AT
GCT CCA GAG AGC ATC CCC AG
GCC TGC AGA GAG CAT TCC AT
GGA CTC ACC CGA GCG ACC C
GGC CGG ATT CAT CTT CTG GGC G
GCG CTC TTC AAC GCC GTC AT
GTA CTG GCC TGT CGG GAG TGG
GGC CCT GTA ATT GGA ATG AGT C
CCA AGA TCC AAC TAC GAG CTT

66 °C
66.2 °C
65.4 °C
65.8 °C
65.5 °C
65.7 °C
65.7 °C
65.5 °C
65.8 °C
64.6 °C
68 °C
68.8 °C
67.3 °C
67.7 °C
62.9 °C
61.9 °C
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